The Tim Ferriss Show - #641: Roland Griffiths, PhD — Life’s Ultimate Glide Path, An Unexpected Stage IV Diagnosis, Facing Death, How Meditation and Psychedelics Can Help, and The Art of Living a Life of Gratitude
Episode Date: December 9, 2022Welcome to another episode of The Tim Ferriss Show. This is a very meaningful episode to me. It is probably the most significant interview that I've recorded in the last year, and it is with ...one of my favorite people and one of my favorite scientists in the world: Roland Griffiths, PhD. Roland has recently been diagnosed with what is very likely terminal stage-four cancer. If you've ever found yourself inspired by someone who walks the walk, this episode is worth listening to. In facing mortality and potentially facing death, what Roland has done and is doing, the perspective he is finding, and the tools he is using, are nothing short of awe inspiring. His example is beyond words, and I wanted to share that with all of you. I hope you find it as deeply enriching and valuable as I did. It is a very tender conversation at points, a very funny conversation, and in many ways, a very profound conversation.To learn more about Roland’s very ambitious project to establish a world-class psychedelic research program—in perpetuity—to advance human flourishing and well-being, please visit GriffithsFund.org.Currently, Roland has received pledges totaling about $14M. This means that he is $6M short of the $20M target, sufficient to support the full research program. To donate, please visit GriffithsFund.org and click “Donate.”For more information about establishing a major gift, please contact Mike DeVito, the Senior Associate Director of Development at mdevito1@jhmi.edu or call him at (443) 278-3174. Donors who contribute $1000 or more and who do not choose to remain anonymous will be acknowledged on the website.Here is Roland’s bio:Roland Griffiths, PhD, is a Professor in the Departments of Psychiatry and Neurosciences at Johns Hopkins University, and founding Director of the Johns Hopkins Center on Psychedelic and Consciousness Research. His principal research focus in both clinical and preclinical laboratories has been on the behavioral and subjective effects of mood-altering drugs.His research has been largely supported by grants from the National Institute on Health, and he is author of over 400 scientific publications. He has been a consultant to the National Institutes of Health, the World Health Organization, and numerous pharmaceutical companies. Roland has conducted extensive research with sedative-hypnotics, caffeine, and novel mood-altering drugs.In 1994 Roland started a regular meditation practice that made him curious about certain altered states of consciousness that prompted him in 1999 to initiate the first study in decades to rigorously evaluate the effects of a high dose of a classic psychedelic drug (psilocybin) in healthy psychedelic-naïve participants. Subsequent studies with psilocybin have been conducted in healthy volunteers, in beginning and long-term meditators, and in religious leaders. Therapeutic studies with psilocybin include treatment of psychological distress in cancer patients, cigarette smoking addiction, major depression, anorexia nervosa, and Alzheimer’s Disease. Other studies have examined non-psychedelic drugs that produce altered states of consciousness having similarities to psilocybin. Brain imaging studies have examined pharmacological and neural mechanisms of action of psilocybin.Roland’s research group has also conducted a series of survey studies characterizing various naturally-occurring and psychedelic-occasioned transformative experiences including: mystical-type experiences, psychologically challenging experiences, near-death experiences (NDEs), Entity and God-encounter experiences, and experiences to which reduced anxiety, depression, and substance use disorders are attributed.Please enjoy!*[05:15] Roland’s earliest personal experience with psychedelics.[11:07] Meditation and interest in altered states of consciousness.[18:32] What is phenomenology?[21:44] Why early attempts at meditation failed, and what made Roland revisit the practice.[29:13] Roland’s work with sedative-hypnotics in the late ’70s.[33:02] Connoisseurs of puff topography.[36:36] When Roland realized the voice in his head wasn’t his.[40:26] From meditation to scientific exploration of psychedelics.[50:29] Entheogens vs. psychedelics.[54:57] Roland’s initial reluctance to experiment with psychedelics.[59:36] Sasha Shulgin, PiHKAL, and TiHKAL.[1:02:12] Bill Richards.[1:03:30] Challenges of the psychedelic trial process.[1:12:41] The results of Roland’s first major psychedelic study.[1:16:46] Pre-existing literature on mystical experiences.[1:18:39] Roland’s more recent psychedelic experiences.[1:27:23] Why isn’t Roland devastated by his terminal diagnosis?[1:42:47] Ego dissolution and anxiety reduction.[1:49:44] The real purpose of this conversation.[1:54:50] A rundown of Roland’s diagnosis and how he’s coping with it.[2:03:44] “Every day is Thanksgiving.”[2:05:39] Gratitude meditation, liver embolization, and other mortality navigations.[2:11:36] Satcitananda.[2:13:18] Eliciting 5-MeO “placebo” experiences without psychedelics.[2:29:14] How does Roland relate to death?[2:34:59] How loved ones can be supportive of someone coping with a terminal diagnosis.[2:38:30] Belief changes associated with psychedelic use.[2:40:45] Thoughts from the crossroads of the quantum, the paranormal, and the psychedelic.[2:52:30] Roland’s endowed professorship and its foreseeable areas of research.[3:09:01] David Yaden.[3:18:23] Is there a contingency if Usona ceases to exist?[3:19:42] Roland’s current prognosis.[3:23:38] Roland’s parting thoughts of gratitude and the road ahead.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Transcript
Discussion (0)
At this altitude, I can run flat out for a half mile before my hands start shaking.
Can I ask you a personal question?
Now would have seemed the perfect time.
What if I did the opposite?
I'm a cybernetic organism, living tissue over a metal endoskeleton.
The Tim Ferriss Show.
Hello, ladies and gentlemen, this is Tim Ferriss. Welcome to another episode of The Tim Ferriss Show.
And this episode is a very meaningful episode to me. It is probably the most significant episode, personally, that I've recorded in the last year.
And it is with one of my favorite people, one of my favorite scientists in the world, also Roland Griffith's PhD. And Roland
has recently been diagnosed with what is very likely a terminal stage for cancer diagnosis.
And this podcast episode spans across two separate conversations, one which was recorded remotely,
and one which was recorded in person in Baltimore. And we cover a lot of topics. It's wide-spanning.
And if you've ever found yourself inspired by someone who walks the walk,
this episode is worth listening to. In facing mortality and potentially facing death,
what Roland has done and is doing personally, the perspective he is finding,
the tools he is using, is nothing short of awe-inspiring. It is beyond words, in a sense.
And I wanted to share that with all of you. And Roland also wanted to share a lot of what we
discuss with the world. And we had gone back and forth on when or if to release this, to potentially release it after his passing,
and ultimately decided to release it now. So I hope you find it as deeply, deeply enriching and valuable as I did. It is a very tender conversation,
at points a very funny conversation, and in many, many capacities a very, I think, profound
conversation. And I will give you the bio for Roland, so please listen. If you want to skip
directly to the interview, you can do that. But here's the
bio, and it's very useful as some context. Roland Griffiths, PhD, is a professor in the
departments of psychiatry and neurosciences at Johns Hopkins University and founding director
of the Johns Hopkins Center on Psychedelic and Consciousness Research. His principal research
focus in both clinical and preclinical laboratories has been on the behavioral and subjective effects of mood-altering drugs. And I'll add this in. One thing that impresses me
and has impressed many people about Roland is he is expert and considered a world-class expert in
many classes of drugs, not limited to psychedelics, and came to them relatively late in his career.
His research has been largely supported by grants from the National Institute on Health, and he is author of more than 400
scientific publications. He has been a consultant to the National Institutes of Health, the World
Health Organization, and numerous pharmaceutical companies. Roland has conducted extensive
research with sedative hypnotics, caffeine, and novel mood-altering drugs. In 1994, Roland started a
regular meditation practice that made him curious about certain altered states of consciousness
that prompted him in 1999 to initiate the first study in decades to rigorously evaluate the
effects of a high dose of a classic psychedelic drug, in this case psilocybin, in healthy
psychedelic naive participants. Subsequent studies with psilocybin have been conducted
in healthy volunteers, in beginning and long-term meditators, and in religious leaders.
All of these are worth looking at very closely and looking up on Google later.
We'll put them in the show notes as well. Therapeutic studies with psilocybin include
treatment of psychological distress in cancer patients, aka end-of-life anxiety,
cigarette smoking addiction, major depression, anorexia nervosa,
and Alzheimer's disease. There are actually many other things, opioid use disorder and so on,
that are ongoing or soon to be started. Other studies have examined non-psychedelic drugs
that produce altered states of consciousness having similarities to psilocybin. Brain imaging
studies have examined pharmacological and neural mechanisms of action of psilocybin. Roland's research group has also conducted a series of survey studies characterizing
various naturally occurring and psychedelic occasioned transformative experiences, including,
but not limited to, mystical type experiences, psychologically challenging experiences,
near-death experiences, entity and God encounter experiences, and experiences to which reduced
anxiety, depression, and substance use disorders are attributed. I encourage everybody to check
out griffithsfund.org, that's G-R-I-F-F-I-T-H-S fund.org, where the focus is on developing a
world-class research program to advance human flourishing on multiple levels. I will be
supporting it, and I encourage you to learn more at griffithsfund.org.
And without further ado, please enjoy this wide-ranging conversation with Roland Griffiths.
So we're sitting here, this beautiful back porch, the fading light entering into a calm dusk here in baltimore we've got celeste verdejo
solis white wine pago del cielo which is god knows where it's got some great constellations on it
don't know doesn't matter right now but it does have spanish So I'm going to say Chile or Spain probably. And we just came
back from a lovely hike. Thank you for that, Roland. At Lake Roland. At Lake Roland, no less.
And I'm so glad to be here. It's been a little while and had a wonderful dinner last night, talked about a million and one things.
And one of the thoughts that came to mind for me, or let me begin with a question. You've had some hesitation, a lot of hesitation for, I think, many legitimate or reasonable reasons why you wouldn't ever want to discuss or might not consider discussing personal
psychedelic use. Let me talk about my personal experience with psychedelics. So I grew up in
the San Francisco Bay Area in the 60s, and invariably within my cohort, I was exposed to marijuana, and I had a few experiences with a psychedelic,
probably LSD, never psilocybin. They were done under recreational circumstances with friends.
They were not meaningful experiences. How old were you roughly at this time?
Would you guess?
Probably a sophomore in college.
Yeah.
And had a few experiences,
but they weren't particularly compelling experiences to me.
They were not the kinds of experiences
that we now know we can elicit pretty reliably under optimized setting
conditions and with proper support. They were not that, and that's actually quite usual with
psychedelics. These can be just very disorienting, confusing experiences. And so those few experiences were something
that didn't make a deep personal impression on me
in the way that we now know
that we have people coming out of our session
saying that was one of the most
personally meaningful experiences of my life.
So that was not it. And in my college cohort,
I don't know what percentage had exposure to psychedelics.
I mean, it's got to be 80% plus. I mean, it would have to be.
Well, I don't think it's 80.
No?
No, no.
In the Bay Area? Where were you?
At that point, I was at Occidental College in Los Angeles. But my friends were from the Bay Area.
But non-trivial.
It wasn't like a prior generation.
I mean, growing up in the Bay Area in the 60s.
No, no.
So marijuana usage was much more normative in many situations than alcohol use.
And there certainly was experimentation with psychedelics. I was neither drawn particularly to
marijuana, and as I said, I had a few experiences with psychedelics, none of which were of particular
interest to me. When I went away to graduate school to study psychopharmacology, and that is psychoactive
drugs. And that was 68 that I went to University of Minnesota. The door had closed.
It had just closed. I mean, it was just about to lock.
Well, it was slammed shut within the academic center.
So University of Minnesota had conducted trials on LSD some years before, and it was already
taboo at that point in terms of research.
It was a third rail in terms of discrediting yourself for being interested in psychedelics.
Now, at that time, were you interested,
or were you like, it didn't register as meaningful enough?
Well, it didn't register with me
as even a possibility to consider.
And I wasn't, in spite of coming from the Bay Area,
I wasn't steeped in the Haight-Ashbury culture.
Dirty, dirty hippies.
Just kidding, folks.
Although Haight-Ashbury is pretty gritty.
Yeah.
If you haven't been there.
Well, it became gritty, but of course, yeah.
I mean, this was home of the electric Kool-Aid acid test.
Oh, yeah.
Stuart Brand's been on the podcast.
He's got some stories of Ken Kesey.
But that was not the crowd in which I was involved with. And my friends who had tried psychedelics,
none of them were psychedelic enthusiasts. And so it was really a non-issue. And I got to graduate
school and it was clear that research wasn't going to go on.
This was 68. 68.
Research of that type was not going to go on.
It never occurred to me to be thinking career-wise that that would be an interesting thing to do.
And because my limited experience was not particularly impressive, I had no particular interest.
So from that point, when does...
All right,
we're talking 68, when does meditation enter the picture? And then when do psychedelics,
even as just a topic of research interest or free time curiosity, even reappear on the radar?
So my involvement in meditation started in about mid-90s, and that opened that spiritual window for me that made me very curious about altered states of consciousness.
And when psych, no like, sorry guys, jeez, I'm going to leave that verbal tick in just so you know after 600 fucking episodes i still have these ticks note to editing
team all right so i'd like to just understand when meditation entered the picture when it
entered the picture in a serious way and then when psychedelics came back on the awareness or interest radar? So I began meditation about 1993.
I got rather quickly, deeply involved,
had a regular meditation practice,
got involved with Siddha Yoga community,
and became incredibly intrigued by the altered states of consciousness
that occurred through meditation.
They're interesting phenomena that arise.
It really turned my interest for the first time on inner experience, deep inner experience.
I'd had some curiosity about meditation back in
graduate school, but it really never took. This time, when I got involved, it did take.
It was interesting, really deeply intriguing to me. It got me reading the literature on comparative
meditation traditions. It rang very closely to spirituality and religious
traditions of which I had almost no prior affiliation and interest in.
I ended up having experiences in Siddha Yoga, having experiences with the teacher of Siddha Yoga,
and this is a tradition that puts high value on this relationship, even on a subtle level,
between the guru and the disciple.
That part really threw me and was kind of repugnant to me from the beginning until I had actually what I considered
an astonishing initiation experience in which I at one point sat before a meditation session.
This was just in Baltimore. And the way Siddha Yoga works, again, the guru is revered. There's a seat at the front of the center,
you know, and if the guru is not present, which the guru, I don't think, ever visited the Baltimore
Center, then a picture of the guru sat there. And I was looking at this picture, and all of a sudden,
the eyes became alive.
And I was looking at the picture, and I was looking into these eyes that were looking right back at me.
And I thought, this is fascinating.
And as I looked more closely, I realized I was looking at my own eyes.
And with that understanding, and this wouldn't be commonly held within the
tradition, I recognized that I was the guru, that I was no different than the guru, that the guru
was just a mirror of who you are. And with that kind of understanding, I was able to join the community in reverence to the guru
because it was in reverence to this kind of deeper interconnectedness that the guru was reflecting back.
And I was able to pranam, you know, bow in front of the guru because I was bowing to myself.
That kind of shifted a frame of reference that allowed me to engage in that
community. And then I started more serious daily meditation practices that I have continued ever
since. But I became just deeply intrigued with that whole area and then had a period of time in which it really became a primary focus of interest to me.
Psychedelics or meditation?
No, no. Altered states of consciousness and meditation.
If I may interject for a second. So before that, were you, and I don't want to paint with too
broad a brush, but more of a BF Skinnerner like, hey, if it's outside observable behavior, we can quantify it and rely on it. Internal experience, too squishy. It's a maze
with no end if you start delving into that side of things. And then after your direct experiences
with meditation, you became more interested in the potential of personally and maybe professionally exploring inner experience.
Is that an overstatement? It might be.
No, no, that's accurate.
Although back in graduate school, when I initially tried meditation, and I did only for maybe several weeks,
I actually got the concept that there might be something interesting here,
that people had developed these methodologies over thousands of years
to explore inner experience.
My training at the time was strict behavior analysis,
which generally ignores inner experiences being irrelevant
because it's not measurable, And it was thought really to be
a nuisance variable. I would have a mentor who would say, yeah, words are just your mouth kind
of flapping around. That's the only behavior there is there. Because you don't have a third
person account of what's going on in terms of subjective experience. And indeed, that's the
nature of the hard problem of consciousness and, you know, ability to understand the validity
of self-reports. But I got the concept that, wait a second, you know, there might be something here,
but the language used to describe it is going to be metaphorical, probably,
because there's no way to verify that what is being reported is correct.
But then, some years later, when I started having these very significant meditation experiences,
all of a sudden that became really intriguing to me.
If you wouldn't mind just describing perhaps one variety of this experience,
I think it'd be helpful for people who don't have any exposure to, say, meditation. What does or unusual to a intrepid meditator experience feel like?
What makes it unlike ordinary consensus reality slash consciousness?
What makes it different?
Well, there's phenomenology attached to these experiences
that will be highly variable.
Just for the muggles listening, what's phenomenology?
I realize I used that word earlier because I want to sound smart.
The nature of the subjective experience.
Okay.
So it could be bright lights, it could be feelings that emerge,
it could be imagery that comes up.
There's a whole variety of what we might call the play of consciousness.
Whatever can appear in consciousness can come up.
If with meditation there may be unusual features to that
or those experiences may come up more intensely than you would otherwise expect.
One of the keys in meditation, what is learned in meditation,
is the ability to look at the nature in meditation, what is learned in meditation, is the ability to look at the
nature of mind, to really understand what it is that's going on in your mind.
How much of that is separating consciousness from content, right?
Like the observer from the patterns or the emotions that are being observed.
When you say realizing what the mind is doing,
could you expand on that?
So the basic instruction with meditation in most traditions
is you have an object of focus.
That might be breath, it might be a visualization,
could be with eyes open and eyes closed, but you're initially invited to
put your attention on a single object and pay attention to it. And so that could be breath,
watching the in-breath and the out-breath. And that sounds like a simple thing, but it's not at all. And it could be paying attention to how the back of your hand
feels. It could be paying attention to what's happening within your mind. There are a thousand
different approaches, but what one is instructed to do is to pay attention and to stay awake to where your mind is. And so, following your breath turns out
to be very difficult. If you sit down and you're told, just stay with your breath, and if thoughts
arise, just let them go. That's a trial by fire. Good luck, monkey mind. You're going to see a lot of hyperactivity. Yeah. And that
drives many beginning meditators out immediately. So you said you started with a few weeks and then
you quit? What happened? Oh, it probably wasn't even a few weeks. Three minutes seemed like three
hours to me. So I just have to, because I think this will give people inspiration also.
So your wife, actually, I should say that. That's actually fun to say. So instead of significantly, your wife was saying to me earlier, so she gave me a fantastic, it was very generous
head and neck massage. She's very skilled. And she said, I'm really rusty because Roland doesn't want massages and he can't sit
still for this long. So I thought that was very hilarious, but also very inspiring, which means
you can have the go, go, go predisposition and eventually still embrace and find tremendous value from these
meditative practices. But what did quitting look like?
Quitting.
Well, you said, I don't know if I've even made it a few weeks. I mean,
with that first period of meditation, did you take a break? Did you just decide this isn't
working? I need something different. What did that chapter look like?
Well, it was a very short chapter. I went to maybe two or three classes from a meditation teacher in Minneapolis and set upon myself to try to meditate each day. And it just was aversive.
It was no fun.
Next time you're going to complain, people,
say this is highly aversive to my delicate sensibilities.
Yes, it was aversive.
You didn't like it.
I didn't like it.
No, no, it was hard and I didn't get it.
Nothing interesting happened,
although I was very impatient for something to happen.
Yeah, yeah, yeah.
And yeah, very quickly concluded I had better things to do
and that there wasn't any value in this for me.
And so then decades later, that situation changed.
When was this initial experiment with meditation?
What year would you say?
So that was probably 1970.
Okay, 70.
1970.
And then around, you said, what was it, 92, 93?
Yeah.
It reemerges.
Why does meditation reemerge at that point?
A good friend at the time got involved with Siddha Yoga.
She started attending this local meditation center,
and I thought, well, that's interesting,
because I'd had a prior interest in meditation but never got it.
And then she called me up one day really excitedly saying,
I'm going on a month-long meditation retreat.
Month.
And I thought, oh, my God, what in the world would that be like?
And there was this kind of mixed feeling I had.
One was almost fear.
It's like, that sounds like torture.
I couldn't meditate for three minutes.
I have to say for people who don't know Roland,
you are one of the most fidgety people I've ever met in my life.
And I say that not as any denigration or insult.
I mean, you have a tremendous forward propulsion.
I'll put it that way.
It's a good thing.
I'm not saying it's a bad thing.
I'm not sure how this is landing for you.
But okay, so the idea of you going to a month-long meditation retreat is crazy it's crazy talk
it would almost be like i don't know saying oh yeah you can go to jail for two months it
sounded like potential torture but yet i had thought about meditation as being something that potentially could reveal something about myself and something I thought I should know more about, and that is my kind of interior experience.
And that maybe there was something to this.
So there was both this sense of fear, but also intrigue.
When was this?
92, 93.
Yeah, probably 92 or 93.
So we can edit this out, but tell me the truth.
Was there any crush on this woman whatsoever?
Oh, she was a girlfriend.
I knew it.
All right.
Just wanted to fact check a little.
Okay.
Yeah.
I mean, we subsequently came to live together.
And I don't know whether we were living together at that time.
We might have been.
As a matter of fact, I think we were.
So we end up, you're considering this insight that could come vis-a-vis greater awareness of your inner experience.
And you go to a month-long...
No, I didn't.
Okay.
She went to the month-long.
She went, okay.
Oh, yeah, no, there's no way I...
I was like, man, that's like,
well, you know, I don't know how to swim,
but I'm going to do an Ironman.
So she does a month-long meditation retreat,
and what comes of that?
Well, she really starts to get engaged with meditation.
So it deepens her practice, this whole experience?
Yeah, she starts a regular meditation practice.
The month-long retreat in and of itself probably wasn't pivotal to her,
but she got more deeply involved in meditation.
And as a consequence, I became more intrigued. And so I started, I took instructions from her, what do you do? And
I can remember, yeah, the first meditations that I did, it was in the evenings after I'd come back from a run, and I would sit down on a pillow in meditation posture
and just try to be present with that.
But at that point, I didn't have any firm instructions in meditation.
But I thought, you know, there might be something here.
It might be intriguing. And it became intriguing enough to me to go to a program down at this meditation center.
It was a weekend program.
What was it that gave you enough positive feedback to commit to that?
Does that make sense?
How did it differ from your prior experience where you're like,
I got better things to do. I'm out of here. Initially, there was just some sense of calm and well-being and then curiosity about where this could go, were I to get more systematically
involved in it. It was like, what is it to stare into the mind when
you've never considered your own interiority, if you will? And that's where I was. I hadn't
paid attention to the nature of mind other than believing and identifying with the voice in my
head that would come up and tell me, you know, oh, good job, or, you know, you really screwed that up.
Where were you professionally at the time?
So I'm a full professor at Hopkins in the Departments of Psychiatry and Neuroscience,
well-established in psychopharmacology, international reputation, dealing primarily with drugs of abuse.
Successful in funding and already had published probably hundreds of publications at that time.
So I was well-established in the field.
This is helpful because I just want to make sure we dismiss any imaginings
that listeners might have of you living in an RV,
sort of into the wild style, running around naked
with Palo Santo or whatever.
That's not the case.
Like you were definitively doing,
you were on track professionally, so to speak.
I mean, it sounds like.
Yeah, and I established as a full professor at Johns Hopkins,
a very conservative medical institution doing rigorous research
and garnering funding and stature, international acclaim for my research,
mostly on drugs of dependence. And at that point, I had done considerable work with sedative hypnotics.
That was a primary focus.
What would be an example of a sedative hypnotic, just so people know?
Oh, Benzoplasmines, Valium, Librium, Ativan, sleeping medications.
So that was one area of specialty that I had. I worked as a consultant
and done a number of drug company-sponsored trials looking at novel drugs for their abuse liability.
For their abuse liability, so just to understand, are you basically trying to identify the worst
case scenarios in that instance with sponsored
research from industry?
Just so I can try to translate what you're saying into lay terms.
Is it companies that are saying, hey, we want to understand what our liabilities are if
we push this out to millions of people?
Let's look at abuse potential.
Here's some money to help us figure it out.
Well, correct.
But FDA also mandates that they assess abuse liability.
For sure. For sure. I mean, it makes a lot of sense on a whole lot of levels.
So we developed methodologies that are continuing to be widely used for assessing abuse liability
of drugs. And many of those procedures were subsequently adopted by FDA and then mandated to be conducted,
trials conducted by drug companies that were bringing new compounds to market.
Yeah.
Because they don't want a compound brought to market that has...
No one wants another thalidomide on their hands.
Well, in this case, no one wants another heroin on their hands.
Kind of wild how that turned out with oxycodone and
so on. I've also been someone who follows my interests. So whatever is of most interest to me,
that's where my research has led me. And so I got really intrigued first with nicotine,
again, as a model for understanding self-administration.
And at the time that I initially got involved with nicotine,
it wasn't considered to be an addictive drug.
Early days.
When was this?
This is in the 60s?
No, late 60s, early 70s?
When was this?
Let's see, I probably started in late 70s.
Yeah, wow, it's wild to think about. People
think this is ancient history. It's not ancient. I mean, for me at least. It's not ancient history.
Yeah, so we ran a number of studies looking at the role of nicotine in the control of cigarette
smoking, and we went down a rabbit hole in looking at detailed behavior analysis of puff topography.
What is puff topography?
Well, with each puff of a cigarette, there's a profile of how people draw on that and what the
duration is and the intensity of that puff. But then you also have the inhalation, the inhalation depth and duration, all of which is
relevant to extraction of nicotine out of that. Connoisseurs of puff topography.
We did, and that turns out to have been a blind alley that I spent a whole lot of time focused on
what actually is the nature of controlling the individual puff.
Sort of relevant if you think about vaping pens and sort of more mechanized, controllable means of administering nicotine, I would imagine.
Like, people must be studying this still. Oh, it's highly relevant, and that is because we know that whatever you're delivering via lung is going to depend on the delivery device.
One of the things that we observed is that the puff duration decreased systematically as the cigarette was smoked.
And we thought, oh, that's interesting.
Maybe there's a satiation mechanism in there.
And maybe there's something subtle about the control of puff duration.
Well, trying to make it last longer, maybe.
Yeah, we ran a variety of studies and found out it actually just had to do with the draw on the cigarette rod.
Oh, because the longer it is, the longer you can drag.
Yeah, and that may change, you know,
factors such as heat and things like that. But it turned out not to be very interesting
with respect to understanding the nature of the addictive behavior of nicotine. But my first
postdoc student in that area, Jack Henningfield, actually came to be very famous in the whole area of nicotine dependence.
And he was a co-author on the Surgeon General's report that recognized nicotine, and at that point, I'd already switched and started to do work with
caffeine because there were lots of people then who were involved with the nicotine stuff. And
I'd gone down this blind alley looking at the puff topographies.
Never fall for the seduction of puff topography, everybody. Don't do it.
Well, but that's what science is. I i mean it looks so orderly and it looked
clean and it was a discrete behavioral measure and so it was really uh seductive attracted to
the seductive but not everything works out and but that's the fun of science is you can follow
your hunches if everything worked out and you there would be a severe problem with the methodology.
Yeah.
Well, yeah.
You learn when to hold them and when to fold them.
Let's zoom out for a second.
So we're talking about a number of things simultaneously.
We're talking about your professional interests.
We're talking about, it seems like, a reintroduction and turning point with meditation as a tool for examining your hitherto, is that the right word?
Largely ignored internal experience, aside from like, yeah, I know when I'm beating myself up and I know when I'm praising myself.
But outside of that, it's just largely unexamined.
I would go even further than that.
Okay.
I don't think I knew when I was beating myself up and when I was
praising myself. You knew those were things, but you didn't have the in-the-moment awareness
to recognize when you were doing one or the other.
I was so identified with the voice in my head that that's all I knew. And I guess if you ask,
I could say, yeah, I'm feeling badly about that because I should have done differently.
But what I couldn't see is that that's just occurring within a larger field of consciousness.
And that voice in my head was not me, that there's a sense of awareness that resides behind that.
And when you start paying attention to that voice and realizing it's not you,
then all of a sudden the game starts changing.
I can remember when I first got involved with meditation
and starting to pay attention to that voice in my head,
and it was brutally judgmental.
I mean, it would say all kinds of, it was just self-judgment,
but, you know, you're stupid.
That was real.
Oh, come on, Roland, you can do better than that.
Yeah, right.
What in the world are you doing?
Oh, vicious. Yeah, right. What in the world are you doing? Oh, vicious.
Yeah.
But I think many, many people live with just that.
And the kind of thought experiment I did is
if that voice in my head were to be amplified brain on speaker,
it would just be really embarrassing to hear what was going on. And I thought,
I was a parent at the time and treated my relationship with my children as a huge
privilege. And I would never talk to my children the way that that voice was talking to me.
And I would say, if I heard a parent talking like that to their children,
I would have a lot of judgment that would come up instantaneously.
I mean, that is not how to nurture a child.
And I'm thinking, but what?
This is my relationship with myself?
You know, good God. Let's get this straightened out.
And so that's part of what emerges with meditation is this mindfulness and catching yourself.
And initially when I would hear that kind of judgmental stuff, I was so identified with it that it was very difficult to dissociate from.
But once I saw it for what it was and say, wait a second, I don't need to hear that,
and then that kind of judgmental voice would just dissipate over time.
But that's just one example of what goes on within our own self-talk.
If that is not who you are, if there's a larger sense of self behind that,
then you needn't allow yourself to get beat up like that.
Okay, if I may just jump in for a second. All right, so we have all of these realizations
vis-a-vis practices. I think that's my new catchphrase for the episode, vis-a-vis. I don't
know why. I sometimes have episodes that are dominated by some bizarre verbal tick that comes
out of nowhere. I think vis-a-vis is my weird tick for this one anyway you have these practices you
have this turning point of sorts 92 93 with meditation we're going to bounce around a little
bit when is your first study published that involves psychedelics in any capacity
2006 2006 yeah but we started the research back in 2000.
Okay.
And started thinking about it back in the late 1990s.
Late 1990s.
So let's just for argument's sake say 97, 98.
So we're talking 92, 93 with meditation experiences.
How do you go from that to then beginning to cogitate on the first germinating seeds of what would later become
a published study. So my interest in meditation became super compelling. I started reading
literature on different meditation traditions, on different religious traditions, and it seemed important to me.
And it really functioned perhaps as a kind of midlife crisis.
By comparison, my interest in conducting new studies on sedative hypnotics
just seemed of much less importance.
Been there, done that.
I could write other grants.
I could get more funding for that.
But so what?
Other people could do that.
And here was something new, a shiny new coin to look at.
And this is psychedelic compounds.
No, no, this is, yeah, about the nature of mind.
What the hell's going on?
And that raises big questions.
I mean, that's the only thing that we really know is our minds.
But in our culture, we never pay attention to that.
And I thought, Jesus, how could I have lived my life this long?
Driving this car for my entire life, and I've never looked at the car.
Yeah.
How is that possible?
Yeah. Never looked under the hood. It never occurred to me to look under the hood.
Never even looked at it. You're just looking at the windshield.
Yeah. And so, that seemed fundamentally important to me.
And there was a level of feeling disoriented
because I didn't understand what the nature
of the meditation tradition I was involved in
and how that fit with other meditation traditions
and where in the world does this fit
within the literature on spirituality and religion?
But it seemed really important and of interest to me,
so much so that I considered dropping out of Hopkins altogether
and going off to the meditation ashram
and really diving into meditation and this tradition. But I didn't
feel secure in doing that. I didn't understand enough about that tradition and where it fit
into kind of a wider field. So I did a lot of reading about meditation, about spirituality. And then I came to be introduced through a good friend, Bob Schuster,
who was head of the National Institute on Drug Abuse at that time
and had been one of my few colleagues
who were actually interested in my involvement with meditation.
And this is in the, now we're talking about what time frame? Late 90s.
This would be, yeah, 97, 98, when I'd go to meetings and my colleagues would say, well,
yeah, what's new?
And I said, oh, well, I've really gotten involved with a meditation practice.
And you could just see their eyes glaze over.
Yeah.
And it was like.
Oh, that's nice. I'll see you next Wednesday at the fill in glaze over. Yeah. And it was like, oh, that's nice. I'll see you next Wednesday
at the fill in the blank. Yeah. So yeah, most of my colleagues just didn't get that at all.
So Bob Schuster, you said, what would he ask you? How did he demonstrate that?
I don't remember the specific time, but it would have been the same thing. I've gotten involved with meditation.
And Bob just had a lot of native curiosity.
And so he would have followed up, well, tell me about that, you know?
And he'd be pressing me for details.
What is it?
Yeah, what are you doing here?
And I think he was intrigued with that. He never got involved with meditation,
but he had wide-ranging interests
and was really a creative individual.
So he was one of my few colleagues
who really showed interest.
It turns out then that he ended up being invited
to a meeting hosted by Bob Jesse.
Bob Jesse.
Yeah.
Love you, buddy.
He's such a good guy.
Anyway, not to foreshadow too strongly, but yeah, continue.
So Bob had started the Council on Spiritual Practices that was very interested in primary religious experiences, and in particular those brought about what Bob
would have described as entheogens, which would be psychedelics. So he was very interested in the
nature of these transformative experiences, and he started this organization, the Council on
Spiritual Practices, and had a meeting at which Bob Schuster
attended, and there was some discussion about launching research with psychedelics.
And so you attended this at the behest of...
No, no, I didn't attend this meeting.
Oh, you didn't?
Okay.
No.
Bob reported back to you.
This is Bob Schuster attended this meeting.
Yeah, right.
Bob Jesse, Bob Schuster, right.
And then the question is, well, who could run such a study?
So let me back up for a second.
Why would Bob Schuster go to this event?
Just out of curiosity.
So, yeah.
Good man.
I mean, I feel like that just defines the best scientists I've ever met.
It's just an extreme curiosity,
because what's the cost?
One day, a couple of follow-up questions.
Why not?
Okay, so he just went because he was like,
yeah, I have no idea what this is about.
Let's check it out.
There's probably more to it.
Yeah, I mean, he would have known
there was something to do with entheogens,
and this sounded like an interesting group,
and he had broad interests, so he went.
So I don't know the details of that meeting, but I do know that at the end of that, there was some talk,
well, what if research were to be renewed with psychedelics?
And just to set the stage here, from, was it 71? I might be getting the year off but once we had the controlled substance to
act is that right am i getting that yeah yeah and and nixon which i would argue is more politically
motivated than scientifically motivated you basically have a psychedelic scientific winter i mean everything is locked down
up until now we're talking about late 90s okay late 90s so it's important for folks to understand
that very little had happened in those intervening years with maybe the exception of Strassman. Yeah. So Rick Strassman had run a study with DMT in experienced users, but other than that,
nothing had been done.
And Jesse's group was interested in what it would take to reinitiate research with more
of the classic psychedelics,
not inhaled or intravenous and in DMT.
And so Bob Schuster suggested that Bob Jesse reach out to me
because Bob Schuster knew that I was involved with meditation.
I might be intrigued.
I certainly was well credentialed.
And he ended up introducing me to
Bob Jesse, who... So many Bobs.
Yeah. And Bob Jesse then came out and we had lunch together. And my interest in
Bob Jesse was that he had this Council on Spiritual Practices that were interested in transformative change.
I wasn't interested in the psychedelics, but he was widely read on transformative change within mystical and meditation traditions.
And so initially I was seeking him as a resource to try to do stress testing about how did I get involved with this group, where does this group fit within other different meditation traditions.
And he was very generous with his time and made a number of books available to me.
Books? What books? Do you remember?
Well, just a reading list on different meditation traditions, different religious traditions.
But he was also interested in what he would have called the entheogens.
Now, just for folks who have no context, why would Bob care about calling them entheogens versus psychedelics. Well, Bob really felt strongly that psychedelics,
just as a term, were beyond, absolutely beyond salvation.
That he felt that at that time,
the whole term psychedelics elicited visions of tie-dyed T-shirts
and lava lamps and the the hate ashbury and and
i'm sad that lava lamps have exited stage love just for the record i think they're fantastic
but yes yeah but the vision there was just so much austin powers flashback yeah tie-dye association is not on the whole positive.
Yeah, there's so much negative publicity that the psychedelics had garnered because of what
happened in the 1960s that there was every reason not to associate with that.
So you have psychedelic, I mean, it's kind of a hodgepodge Greek etymology,
but mind manifesting, right? Then you have entheogen, so theo, like theology, or theobromine,
food of the gods, chocolate for you chocolate lovers out there.
But the theo is God. So that's the experience of God within.
God. So entheogen is in Genesis, which we. What should we make of that term, entheogen?
What does that mean?
Just simply speaking.
To engender the experience of God within.
Yeah.
And these substances then would be claimed to be relevant to that.
But of course that uses the God word, which is problematic in and of itself.
It's a very narrow casting of what the psychedelics can do.
I mean, yes, they can produce experiences of spiritual significance,
but they do a whole bunch of other things.
And they had been termed psychotomimetics for a long time.
Yeah. Still sometimes apt, I think. But yeah.
Well, they are. Yeah. They were thought to be models of psychosis. And that was thought to be
their primary initial interest. Let me ask a pointed question here.
Without personal experience, after your initial experiences, how did you get to the
point where you decided to dedicate your resources to studying psychedelics?
So when Bob Jesse prompted me to consider running a study with, in this case, psilocybin. And at that time, we would have called it a
hallucinogen. So we wouldn't have called it a psychotomimetic. We would have called it
a classic hallucinogen. And so the term psychedelic has since been rehabilitated. And so now
we're free to use it once again. But at the time, it was too edgy to use.
So the thought going in was, can we study this?
I was familiar with the work that had been done.
And now I got caught up on my reading of the work, particularly from Harvard.
But there was a lot of other research on psychedelics
from the 50s and 60s.
A lot of which was in the context of then alcoholism
and now alcohol use disorder.
So that was one of the central therapeutic targets
from that early work, as was end-of-life anxiety and depression,
both of which have now resurrected,
and we ended up running a significant trial in cancer patients
who had anxiety and depression at end-of-life.
And just this last week, Michael Bogenschutz from NYU
has published a very important study showing that psilocybin is effective at treating alcoholism.
Those are lines of research that were really started in the 50s or 60s. forward then to the current moment, not as we're sitting
here on your patio, but
rather the moment that you
freeze-framed, which is
Bob Jesse suggests
a potential
study or research
looking at psilocybin specifically.
That is
roughly what year would you say?
It would have been maybe 98.
Okay, 98.
Yeah.
Funny enough, I just have to say for you,
you might find this entertaining, in 96, I think it was 96,
I was at Princeton, I was a psychology-focused undergrad
hoping to specialize in neuroscience.
I think it was around the same time
I would have submitted my final term paper
for a psychology class with Bart Hobel,
who did all sorts of interesting research,
discussing the neurological,
I mean, this is fancy talk,
but neurological correlates between LSD-25, otherwise known as just LSD, and REM sleep.
So basically the exact same time.
I just think that's a funny coincidence. from let's say 97, 98, let's just say 98 for simplicity,
to your next personal use of psychedelics
and what came of this new reentrance
on a personal level into psychedelics?
I think importantly, at least to me,
is that when I decided I would conduct a study with psilocybin,
number one, I didn't have any significant prior experiences.
Well, you had none with psilocybin, right?
None with psilocybin.
Presumably, you used LSD back in the day, so no direct experience to psilocybin.
No direct experience with psilocybin, but nothing of interest with
psychedelics. Why did you say yes to Bob or continue to have that conversation? Because I was
deeply interested in altered states of consciousness, and I thought this would be a way to
use the tools of my trade, I'm a clinical pharmacologist that runs drug trials,
to conduct rigorous research examining those.
At that point, I had plenty of experience running clinical trials,
designing novel ways to assess subjective effects in different feeling states.
And I had a lot of credibility within the field in terms of running that.
So this was, in some ways, right down my alley.
Let me ask you this.
At the time, were you tempted to possibly have a firsthand experience with psychedelics and you subverted that because of other priorities?
No, I had zero interest. As a matter of fact, I think if anything, I would have been deeply
reluctant to be exposed to a psychedelic because I was already on a meditation path,
and I didn't know how that would interact with that. And in fact, within meditation traditions,
there's a long history of prohibition of use of any psychoactive substances. And as it turns out
now, since we've done research with long-term
meditators and beginning meditators, I don't think that there's any significant adverse
effect on meditation of using a psychedelic. But at the time, I didn't know that. And furthermore,
I frankly was suspicious of the psychedelic enthusiasts.
There's a cohort of people who would wax excitedly.
You're using some fancy terms for folks.
So cohort, et cetera.
So what were you seeing that you didn't like?
Where you're like, I'm not sure those are my people.
Yeah, well, so within the scientific community,
yeah, they were not psychedelically enthusiastic researchers
because no human research could be done.
I'm just curious, at what point did you become aware of Sasha Shulgin?
We don't have to spend a lot of time on this.
I'm just wondering, like, from a chronological perspective,
because that guy has some, I he has some some real credibility he had he's passed
away of course but you see i probably would have read pico or tico his classic books at the same
time i was just getting familiar with the whole field.
For people who don't know, P. Col was the first. That's phenethylamines I've known and loved.
I think a chemical romance, maybe a chemical love story. One of the two is the subtitle.
Amazing book. Okay. But by and large, not many people in your scientific peer group
who would want any type of association
with psychedelics whatsoever. Or is that too strong? No, no, no. It was, at that point,
it still was considered to be a non-starter. Except for Rick Straussman, no research had
been done with these drugs, certainly not in psychedelic, naive individuals.
Yep. And he had worked with experienced subjects.
Correct.
Yeah.
Yeah. He had gotten permission to give DMT to experienced individuals. clear at all that you could even get a trial approved to administer a significant dose of a
psychedelic to psychedelic naive people and so when we initially submitted that protocol
when did you initially submit that would have been probably 99 yeah it's so i judged the
probability of even getting the protocol accepted by my IRB and by...
What is it? Something review board. What does the I stand for?
Institutional.
Ah, that's right.
Institutional review board.
And essentially they're the ethical approval group within an institution, in this case Hopkins.
If you want to do week-long facts, you're late to the game, folks.
Could have done that a few decades ago, but not anymore.
That's because you will not get IRB approval.
And then FDA approval was equally uncertain.
So it wasn't clear we could do this.
Why did you decide to throw that Hail Mary?
Because I was really interested in altered states of consciousness.
And now you have a means by which, in a single session,
you could potentially induce a significant altered state.
Yes.
So a key component in us doing this research was finding Bill Richards,
who had formerly worked at Maryland Psychiatric Research Center.
Didn't he administer the last legal dose of psychedelic assisted psychotherapy?
He did.
Yeah.
He did.
And so he had been involved in this.
He himself had had psychedelic experiences before they were made illegal. And he was a clinical psychologist
in Baltimore.
How did you find him?
Well, Bob Jesse introduced him.
Oh, Bob Jesse, the source of all good things. I mean, Bill Richards is very, he's very skilled.
He's very skilled, but I would also count him among the true believers.
For sure.
He was a skillful clinician, and I wouldn't have had the courage to study a high dose of a psychedelic
absent someone who could assure me that they knew what they were doing.
Hey, look, I've been shot into space.
Let me tell you what it's like.
So we made a great team.
Bill was well-grounded in guiding sessions.
I was the skeptical scientist.
And we designed a study that kept Bill entirely blinded to the study conditions.
Meaning he would not know, as one example, who has received an intervention,
meaning an active dose versus a placebo dose, among other things.
The design of the study is a little bit complicated,
and we used a high dose of Ritalin as a control.
And people were told that they would have three different sessions and at least one session would involve a moderate to high dose
of psilocybin. So they were told that. But other sessions could involve administration of, I think we had 13 other psychoactive compounds
like nicotine or diphenhydramine or cocaine.
So diphenhydramine would be Benadryl for people.
Yeah, yeah.
But drugs that have a whole variety of different kinds of actions.
Just from a study design perspective,
why not have a few controls in that sense versus having many controls?
We had a single control, and that turned out to be Ritalin.
But importantly, the instructions to both the guides and the volunteers was that they could receive a much wider range of drugs. Now, among the drugs they could receive were methylphenidate, Ritalin, and psilocybin.
And they were told that on at least one session, they would get a moderate to high dose of
psilocybin.
Why was it important to tell them that they could receive anything ranging from Ritalin
to psilocybin to the diphenhydramine?
We wanted them to be open to whatever experience they had. We did not want to
tell them specifically, this is going to compare psilocybin with Ritalin, because then they would
be paying attention. They might look up the effects of what they're receiving.
Yeah.
So that blinds them.
They did not know that, in fact,
everyone was going to get a high dose of Ritalin.
Everyone was going to get a high dose of psilocybin.
And we further created a blinding condition
with a limited number of subjects,
giving them on the first two sessions just methylphenidate, and on the third session,
psilocybin. And again, it was to throw the guides off, the study staff off, the volunteers off in terms of what to expect. So I think we did as good a job as we could. Can I interject for just a second? I want to say, because we
were talking last night about this conversation and the risk of you seeming biased because of things we're gonna we have still yet to discuss we'll get there but
my thought as a again as a tourist like a very enthusiastic amateur but not by any stretch a
legitimate scientist what i believe or not by it's not even a belief it's not a belief it's
a statement of i think reasonable objective fact which is that
the scientific method and proper study design should reduce bias even if the experimenters
have extreme bias and i'd love just to get your take on that for a second because
for instance i think bill Bill Richards is a genius with respect to
many facets of what he does. He is an incredible clinician. I mean, really outstanding, as is
Mary Cosmano. I want to just mention that also as an additive. But that said, he is a true believer,
as you put it. So how do you include someone with that skill set
in a study design while ensuring that any bias, pre-existing bias, does not manifest in the
clinical outcomes because of experimenter bias? And that's part of the reason why I wanted to
have this conversation, because I feel like as long as your study design is immaculate,
whether the experimenters are biased or not, ideally they are not biased, but even if they
are biased, that is why you have people like Feynman saying, you know, the easiest person
to fool is yourself and therefore precaution, precaution, precaution, precaution.
But it seems to me that the,
I brought in a lot of different elements in this conversation,
but that the experimental design itself
and proper implementation of scientific methods
should hedge against bias,
even if it exists in experimenters.
Is that just a wine-infused muggles understatement?
Or is there, I mean, what would you add to that?
The nature of many clinical trials,
if they're double-blind and rigorously run,
there's no way for the people running the study to know what those conditions are. And in particular, if you can't break the blind because of apparent effects of the drug,
then you're safe. What do you mean by breaking the blind?
Well, breaking the blind is a particular problem with research with psychedelics.
You mean niacin?
Yes. Niacin doesn't equal the reports of psychedelics that people have read on Arrowhead?
Yeah.
And so it's a deep problem with psychedelic research,
and it's not been solved yet.
We don't have adequate controls that would completely put skeptics at peace
and not thinking that there wasn't an opportunity for bias.
So you worry about expectancy effects on part of both the therapist
and on part of the participant biasing the outcomes.
If I may, because I've had enough of this fantastically traditional neurotoxin to embolden me.
Let's assume that you are Roland, heavily biased towards psychedelics as you are
involved in a study design that nonetheless mitigates against experimental bias.
Even if bias somehow influences the results, would the actual clinical
outcomes of psychedelics not still be impressive with a number of indications? Blinding with
psychedelics is so hard, right? I mean, it's just like everybody who gets nice and knows it's not.
In our first study, we were dealing with psychedelic naive individuals.
So that was important because what we didn't want is people who had experience
who could immediately identify.
Who could benchmark against whatever they're.
Oh, yeah.
And furthermore, you would have had a selection bias.
People who had bad experiences with psychedelics would say,
hell no, I'm not going to
sign up for that study. And then if you had positive effects, you wouldn't know how much
of that was selection bias. So that was then, this is now. We're now the widespread
cultural enthusiasm, overblown enthusiasm for the effects of positive effects of psychedelics it'll
pay your bills for you oh my god this stuff's amazing yeah it's much more problematic now
to conduct a clinical trial because many of your participants are going to come in with
strong cultural expectation of profundity. Huge, huge expectancy effects.
And that makes conduct of these trials even more difficult.
And actually contributing to that is if you compare the psychedelic to an inactive placebo,
and you have people with high expectancy effects,
you have the potential for huge disappointment effects.
And so your placebo is no longer a neutral indicator
of what happens if people don't get psilocybin.
Yeah, you're dealing with all of the consequences
of people having hyped up expectation
and essentially knowing that they've drawn the black straw.
Okay. So let's look at the inverse or the converse, I'm lacking the vocabulary at this
point, honestly, folks, of drawing the black straw. So you then at some point decide to
personally re-engage with consumption of psychedelics? How does that
happen? When does that happen? What is the outcome? Just for people who are listening,
we're sitting here. I love recording at dusk because everything changes so dramatically.
So I can't even see your face right now. We're sitting on the patio. It's very dramatic. The
light of the recording device is alive and well.
All right.
Tell me, Roland.
So I had become intrigued at studying these back in the late 1990s.
We enrolled our first volunteer around 2000.
We published our first paper 2006.
It's a big paper, just to make an understatement.
What's the name of the paper, if people want to look it up?
Psilocybin Occasions, Mystical Type Experiences,
Having Enduring Meaning and Spiritual Significance.
There you go.
All right, so translated to Long Islandese, since that's where I'm from originally.
With these-
Psilocybin occasions, big fucking deal.
Mystical experiences with some durability.
Well, no, with-
Incredible durability.
Yeah, substantial change in worldview, attribution of positive changes in moods, attitudes,
and behaviors and experiences that are rated
to be among the most meaningful of a person's entire lifetime.
Okay.
Okay, so that was the initial finding that got my attention big time.
This is going to sound like a dumb question,
but why did it get your attention?
Because I'd never seen anything remotely approaching that
after having studied dozens of different psychoactive compounds.
So at this point, I've given high doses of sedatives and opiates and stimulants and,
you know, other chemicals to people who are both drug experienced, drug abusers, and drug
naive.
So I'm really accustomed to understanding and being able to assess the subjective effects
and what people say about them.
And different drugs produce different kinds of effects, and people report different things,
and I knew that. And so that, you give a dose of psilocybin and they're going to produce effects,
in this case an unusual profile effects. Yeah, fine. What makes that any different?
What makes it different is that months after the session, people are saying that experience
two months ago was the most interesting, most meaningful experience of my lifetime,
or among the top five. Not what people say about
caffeine, cocaine, or methamphetamine. No, very different. So people, if you give them a high dose
of cocaine, they may experience euphoria and really get high from that. But if you ask them
a day later, much less a week or a month, what was that experience?
They're going to remember it like we remember anything in memory. Oh yeah, I remember I got
really high that day. That was kind of fun. But it's a memory. There's no enduring meaning.
And yet people are coming back months later saying this is among the most meaningful
experiences of my entire lifetime that's really weird but it fits with literature on mystical
naturally occurring mystical experiences so people have these and you've done a bunch of this reading
in the meantime oh yeah what type of stuff were you reading? How did you find it? I mean, there's a large literature on mystical experiences, starting with William James
at the turn of the century, where he wrote varieties of religious experience. But there
had been a whole series of research studies on mystical experiences, but they were really elusive because they occurred
erratically or capriciously. What do you mean by capriciously?
You couldn't predict when they would occur. And sometimes it would seem to be random occasions
where people would just walk out on the beach and have this epiphany that they would claim to be life-changing.
It was not replicable.
Yeah, we certainly didn't have conditions under which we could elicit those experiences reliably.
So they weren't, in that sense, they weren't amenable to scientific study.
So to do prospective scientific research,
you need conditions under which you can produce an effect reliably,
then you can compare that to conditions in which you don't give that drug
or you give some other substance,
and you can do that prospectively,
and then you can compare those groups.
So you have all the tools of the scientific method at your hand to deconstruct.
So Roland, it is rare or infrequent that researchers talk about their personal use of compounds they are studying or focused on.
Is there anything you'd like to say about your personal use of psychedelics? Thanks for asking, Tim, because I, among any number of researchers working with psychedelics, have been really quite reluctant to talk about any personal use, and
for good cause, because these compounds were so misunderstood back in the 60s and so branded with all kinds of mistruths that there's historically been suspicion
among people who may have even had experience, much less people who are proponents and have
become enamored with their effects. And what I've said repeatedly with respect to my launching our research with psilocybin was that prior to that time,
I had no meaningful personal experience. Again, I was deeply interested and committed and
satisfied by my own meditation practice, and I didn't know that that wouldn't be a significant distraction. So for years afterwards,
it didn't occur to me to take a psychedelic, nor did I have access to psychedelics.
You can't just break the quadruple locks and use the tightly controlled Schedule 1 compound. Yeah, me of all people had no access to the drug supplies that we have locked away under very tight security. disadvantaged as a clinician talking with volunteers having gone through these experiences,
but not knowing fully what that experience was like at a personal level. And so there came a
time, and it was at least six years after the publication of our paper, and that would have been 12 years after the initiation
of our research, that I had an occasion to have a higher dose experience with a psychedelic. And I've
now had a few of those. I'm by no means an enthusiast, but I certainly understand the nature of those compounds.
I can now confirm firsthand that the overlap with the kinds of experiences that can emerge in
meditation and in breathwork, because I've also had experience with breathwork,
and other kinds of practices that elicit these changes in consciousness,
I can confirm that they're of the same flavor.
There's certainly differences, but they're of the same flavor.
And again, that occurred only well after we had published our first study,
we had published the follow-up study.
We were largely completely through our cancer trial and significantly through our beginning meditator trial.
And we also had run a psilocybin dose effect trial.
So the research had continued apace, and it's only more recently that I've had these experiences.
Let's just flash forward to the 60 seconds before you are about to take your own personal
psychedelic drug. You're about to have your first, after a long hiatus, your first personal
experience. In those, let's just call it five, 10 minutes, an hour before you're
about to take it, what are you taking? Where are you? What's going through your head?
I ended up obtaining some 2C-B, which is a substituted amphetamine.
So it's structurally related to mescaline
for people who don't know what phenethylamine is.
Yeah, yeah.
But it produces classic psychedelic-like effects.
So I took a really low dose of 2C-B.
How did you decide to do that?
I'm just like, to go from zero to one, I mean, this is a big step.
Okay, okay.
But it was done.
I was alone.
The intention was to go deeply into meditation.
Why 2C-B of all the things?
It was the only thing that was available to me.
So what happened?
Went into meditation.
You're meditating now after having ingested the drug?
Well, I started by meditating before.
And then...
Were you nervous?
I was curious, maybe a little nervous.
Yeah, I would say, yeah, I was nervous.
But it was a low dose, and it started opening up very familiar territory
within meditation. And there was a sense of opening. And at that point, I had done enough
research about the features of the classic mystical experience that I could look at my experience and try to interpret
it within that framework. So one question is, is there a sense of unity? Is there a sense of
connectedness or a void, which classically occurs in meditation, the sense that there's a total emptiness or total fullness. And that was there.
Is it sacred? Is there something precious about this experience?
Are you analyzing this while you're having the experience?
Yes. Oh, yeah, absolutely.
I don't say it to malign in any way.
That's what this project was about. It's what the hell are these things?
And yeah, how do they fit into the experience framework that I had?
Now, 2CB, fortunately, I would think in this instance,
provides you quite a span of time within which you can reflect in this way.
So it's not like a 5 to 15 or 5 to 20 minute experience
with NNDMT or 5 mO DMT inhaled.
Instead of that, you have, who knows, what would you say?
6 to 10 hours, 6 to 12 hours?
I mean, something like that, potentially, with TCB.
Yeah, but this was a threshold dose.
I don't remember what the dose was,
but this would be in what we might call microdose range.
I got it.
Okay, so bunny slope, but nonetheless.
Yeah.
You know, the features of this unfolded the sense of unity,
the sense of sacredness.
Was it true?
Absolutely true.
And I ticked off all the qualities. And then I remember taking my phone
out and writing a memo to myself. And it was just three words, it's all true.
What did that mean to you?
Oh, it meant to me that the nature of the mystical type experiences is confirmed.
It fits with what I know about meditation, and it's quite amazing.
It wasn't totally unfamiliar territory to me, though.
I mean, this was territory that I had explored in meditation. So it wasn't brand new in that sense, but I'd also
been meditating long enough, sometimes hours a day now, and at this point for years. And what I
realized is the coherence of that experience and kind of the tuning of it was remarkable because I'm all too familiar with spending hours meditating without such experiences.
That's all true.
What's interesting to me now in where I find myself with this terminal cancer diagnosis
and reflecting on how I'm managing that personally. And as we've discussed, this sense is
one that I have a sense of equipoise and balance, curiosity, wonder, gratitude, a sense of celebration
for the preciousness of life. And the question that has emerged to me, but to others watching me,
is how do you account for that? Because one might think that a terminal diagnosis would be
devastating. And I think I can't possibly know how to account for at least how I've managed that diagnosis over these first
eight months. But what I would highly suspect is that it has a lot to do with my long history of
meditation practice, and it's informed by some of the experiences that I've had with psychedelics. So with regard to the meditation,
there's a real training of the nature of mind,
watching one's mind,
de-identifying from the voice in the head,
and making optimal choices
about how one wants to proceed in one's life.
The same is true with a psychedelic experience. In fact,
that's exactly what we do in preparing people for a psychedelic experience. We give them a
crash course in mindfulness, telling them that all kinds of phenomena may emerge during the session,
and the posture that we want them to take is one of interest and
curiosity. If something fearful arises, be it a demonic vision or just fear, the right approach
is one of interest and curiosity, and to approach in spite of the fact that the hair on the back of your head may be standing on end.
Because if that's inspected deeply enough, one finds that those experiences change.
They're objects of consciousness.
They can be very informative, and there's absolutely no reason to run from them.
There's every reason not to run from them
and nor do you want to fight them
because all that does is reify them,
empower these objects of mind
into something that they're not.
They're part of the play of broader consciousness
that's deeply informative.
And one gets those learnings, if you will, with psychedelics in a very powerful
way, because psychedelics can be so destabilizing to any normal sense of consciousness that at times
one feels that one is walking along the razor's edge between insanity and transcendence.
But one recognizes the feeling that that's a very precarious tightrope to walk.
Since you have both the meditative experience over decades and deep, dedicated practice in that capacity. Were your psychedelic experiences simply reminders
of insights you had already gained
and therefore you appreciated them as tools
but they were not additive to your personal navigation
of the world or lens through which you look at the world
and life or did those psychedelic experiences add something that was
not duplicative of your meditation experience? The psychedelic experiences and what I've learned
about the nature of mine converge incredibly with the meditation experiences. But I have to say that sometimes characterized psychedelics
as the crash course in mindfulness.
I mean, it really is.
It's such a powerful teaching in a way that comes across much more forcefully,
at least for me, than meditation practice.
But once I can see that through the lens of a psychedelic experience,
then I can bring that into meditation. So I think my meditation practice has undoubtedly deepened
because of that. There's a lot of overlap. I guess what I would say is that psychedelic Psychedelic experiences have often, for me now, more intense in consciousness and the wise use of how to
pursue or hold those in a way that you don't end up identifying, particularly with the negative
constructs that arise. It's a peculiar thing, but when something negative arises, be it a demonic figure or something like that,
the tendency is wanting to avoid it, to escape it.
And if you try, it's just going to chase you forever.
And you'll have an absolutely miserable time for the entire duration. And if you're able to turn and be deeply curious about its nature,
then it starts to change. So it really is this invitation to face what initially appears to be
the dark side of things, the most frightening things. And I would have to say,
terminal cancer diagnosis might well qualify
as emblematic of such an experience.
And so perhaps, I don't know,
but perhaps psychedelic experiences
that had negative valence qualities to them and how I learned to
navigate those could have been very important to me in how I came to find myself navigating the
diagnosis. I know a number of folks also, as you're describing this several like Sam Harris come to mind
who's spoken about this publicly but who first through the experience of
psychedelics saw certain possibilities that had been invisible to him prior to
that that then led to his dedication to mindfulness and meditative practices and
as you're describing say a demonic force or let's just say in a psychedelic experience
if you face a godzilla sized figure some type of giant dinosaur with a clown head it may be
in a sense training wheels for what you can do in sober waking life with meditation, but it's an easier opportunity to say,
wait a second, this is a Godzilla with a clown head.
Clearly, this is not something I can just take for granted
as a real entity.
How can I be curious about this?
So you have these dramatic examples
that allow you to disidentify with the content,
perhaps, of your experience and start to examine it.
Whereas if, and I'll speak for myself because I also tried meditation many times and quit
initially, to deal with maybe the subtleties or the embedded stories around depression or sadness
or anger that have been baking and accepted for decades is a harder task than saying, wait a second,
I remember Roland told me before I lay down on this couch and put on these eye shades
that I should be curious about this type of experience. It is scaring me. All right,
this Godzilla with a clown head, I'm going to ask it who it is. I'm going to in and through,
I'm going to do the whole thing. And it's a practice dojo with extreme, in some cases,
extreme examples that allows you then to come back to your normal waking experience and begin
to examine your thoughts or at least entertain the possibility of examining the content.
And one thing you said, I just want to emphasize for folks, I've seen in real time
with you multiple times now, it's not just a party line and a happy face that you're putting on. I
mean, we spoke a few days ago and I called you and I asked you how you're doing. And you said,
never better. And in the meantime, you said, I'm not kidding. I am. And you've had various meetings,
including a meeting this morning, turning out different, or at least becoming aware of different options and decision trees that you could follow.
And it seems to me that oftentimes people may have the in and through as a line in the
scripture of psychedelic navigation.
But there's also the option of looking at your mind or your psyche responding
to your environment, your circumstances, and to separate the observer or just the
canvas of consciousness from what is being projected upon it and to say,
oh, I can see how I could go in five different directions. I don't think it's helpful to go in
these four directions. I choose not to go in those four directions. And that's different from fighting
with the content of your consciousness without being aware of the distinction. Does that make
any sense? Yeah, oh, that makes a whole lot of sense. Across a number of therapeutic indications,
not to mention our studies with healthy volunteers, very often people come
out of these experiences empowered, a sense of self-efficacy, a sense of freedom of choice,
seeing the vastness of the decisions that they could choose to make and that are available to
them that had previously just been foreclosed.
I mean, most dramatically, people who come in identifying themselves
as an addicted cigarette smoker or addicted alcoholic.
And through these experiences, they come out saying,
wait a second, I actually have agency here in a way I didn't appreciate. I can choose. There's another
piece of the psychedelic experience, and that's a willingness to engage with something that feels
like it's suffering. So you don't end up approaching the Godzilla. And incidentally,
sometimes it doesn't have a clown face. It has the most terrifying face that your psyche could possibly create for you.
So through these experiences, not only is there a landscape of consciousness,
there's a willingness to engage, interact with those fearful objects of consciousness,
the Godzillas, if you will,
knowing that it's going to enhance your fear initially,
but by pursuing that, you're going to end up resolving the problem.
And that's precisely what happens with the addictions.
So the person who's identified themselves as an addicted cigarette smoker
really has made a choice that they can't bear the suffering
that they know that they could experience when they quit smoking.
They know that they're going to crave,
and they fail to do that time and time again.
And here they're having just faced down Godzilla.
You come back out and say, well,
can I put up with some craving that I know is going to be time limited?
You know, can I put up with some tiredness or whatever it is?
Damn right I can.
I mean, the payoff is much too great.
So there's this sense of personal empowerment.
And the other thing is, so these experiences with psychedelics
inform the meditation practice. They inform a deepened sense of mindfulness. But let me also
just remind us, it's called meditation practice. It's practicing to deal with the nature of mind, in this case, with the intention to bring that off the cushion, to bring that out of the practice into moment-to-moment life.
And that is the ultimate objective. be something that some people might identify as enlightenment, and I certainly am not making
any claims to having achieved that flawless moment-to-moment state.
But that is the invitation.
How do we keep remembering what these teachings are?
How do we keep bringing ourselves into the astonishing celebration of the present moment.
Let's, if we could, just talk about the cohort or cohorts of patients
who have used psychedelic-assisted or psychedelic, you can call it assisted,
therapy, in this case psilocybin, for end-of-life anxiety. I do know of several examples
of highly, I don't want to say decorated, but accomplished master meditators who nonetheless,
upon facing mortality, have responded much like anyone would or would expect themselves to with tremendous
fear and depression and so on. That has not been my experience, although you've certainly
had moments as you described. It has not been my experience with you. And my question is,
and you can make this personal or you can direct it at the cohorts. That's not accidental that I'm giving you that choice. How much of their reduction anxiety, if any, seem to be correlated to
ego dissolution? So the experience of existing and observing and experiencing without what we assume often comprises the self, this I, this Tim that has characteristics and a name and a place and a certain physical manifestation.
Even in the absence of that in psychedelics, you can have the experience of experiencing and observing.
What did those people attribute their reduction in anxiety to?
Several things, but we use several different descriptors for the nature of what we think are
some of the transformative effects of psychedelic experiences. Eco-dissolution is one, but my sense of that is it actually misses some really
important components that are captured in what we call the mystical type experience.
So the mystical type experience has one factor in it that is equivalent to ego dissolution. It's the unity of all things that can be experienced as
the absence, the void, the complete void that is completely empty yet completely full at the same
time, paradoxically, you know, or the sense of the interconnectedness of all things. But in being
interconnected, the personal self can dissolve
or is just part of a much larger whole.
That's a piece of it.
But having an ego dissolution experience can also occur
under conditions of extraordinary fear
and create incredible psychological destabilization subsequently. But the mystical
type experience has that. It has this component of the preciousness or the sacredness of the
experience. So there's something about the valence of this experience that's absolutely precious.
And then it has this noetic quality, the sense that the experience is
absolutely true. There are other features, positive mood very often, a sense of love or gentleness,
openness, and transcendence of time and space, and ineffability, but those strike me as lesser
important qualities to the enduring nature of these experiences. But we now have shown
across a number of different clinical studies with clinical outcome measures and studies in
healthy volunteers that the magnitude of the mystical type experience, the completeness of that,
correlates really well with the enduring positive changes in moods, attitudes, and behavior.
Now, it's not completely determinative.
There are other features of the mystical experience, or of the psychedelic experience that we've also developed questionnaires
to probe that also appear to be really important. And one very important one is psychological
insight. One can have an experience that is absent features of the mystical experience, but is given to some kind of profound new understanding
about how one's holding themselves with respect to whatever the problem is.
And those experiences of insight can also result in abrupt, irreversible changes
in how someone proceeds. So a metaphor, you know, you send someone from
some sheltered background, they come from a tightly evangelical community that believes
in literal interpretation of the Bible, does not believe in evolution, they go off to college, they take a couple biology courses, and they go,
okay, yeah, this evolution is a thing. And that understanding, I don't know if that's reversible.
I mean, once you come to an insight of that being true, or you come to an insight that you're in an
abusive relationship, that the person that you feel closest to is actually truly
abusing you, if that's true, if it's a real insight, then that can be irreversible. And so
those kinds of marked changes can occur. So with respect, particularly about how people
with terminal diagnosis, what their attitudes about death and dying,
and why the anxiety and depression they're experiencing becomes less,
is probably multifaceted.
So the therapeutic effects there correspond with the mystical-type experiences.
They're probably insightful-type experiences. They're probably insightful-type experiences. There seems to be, very often, a decrease in fear of death, and there's a tendency
toward the belief that there's something, and that can take incredibly different forms and
different people, something that may survive death. And whether that's a full-on theological compatible account
or whether there's some just mysterious sense
that there's something that endures after death,
that belief tends to be enhanced.
Let's return to the personal for a moment, and we don't have to belabor this, but I certainly
would be interested to hear you answer the question as to why have this conversation?
Why, among other things, would you feel it's potentially beneficial, maybe that's not the right adjective, but the right time to discuss or mention personal use, for instance?
Why do that?
I'm going through an experience of a lifetime here.
And it's one of just astonishing celebration and joy. And I would say, just with respect to how I feel about my own
very probable impending death, that it's not that I hold strong ideas about the continuance of life
or consciousness and certainly not reincarnation or classic heaven. I don't hold those beliefs. I feel agnostic toward the idea that we, I mean,
we truly don't know what's going on here. So it's like this, I'm really curious about whether
there's any experience. And after death, and it's kind of exciting
that I'm going to have the opportunity to find out
well before most of the listeners here will know.
So I'll know something you don't,
and I'm really interested in that.
But at the same time, I don't know what happens.
But what I do know is that this gift we've been given to be these sentient creatures,
walking around, being aware that we're aware with just a little bit of contemplation,
a miracle is not an inappropriate descriptor of where we find ourselves
and how this has come about and why we've been gifted with this opportunity.
It's unknown to us, but it should be a source of incredible gratitude and joy and celebration.
And that's what I really want to communicate about my own experience along with the invitation to have others join me,
hopefully without the terminal diagnosis,
but join me in this celebration because we deserve it.
And in the largest sense, what my deepest desire is,
is to have that sensibility awakened in humankind all over. I mean, we need that for
the survival of our species ultimately.
It leads to this sense of wonder and pro-social tendencies and mutual caretaking.
There's no easy way to get there,
and the way to get there is certainly not to dump LSD in the water supply.
I wish you told me this yesterday.
Just kidding, just kidding. Because I think the culture
needs to develop institutional structures to hold and support and work with these kinds of
experiences in a way that doesn't undermine culture more broadly. And I think these substances can do that. So I see it as this
co-evolutionary opportunity that our cultural institutions need to co-evolve and learn to
support this. And so that could be some number of generations. But ultimately, the basic message I have is, you know, let's awaken.
Join me in this larger awakening project.
And there are many, many, many people already on it.
And it takes different forms.
And it's not just psychedelics.
But it is the awakening to the huge benevolent mystery. And how one wants to put language around that
is completely up to where you find yourself in culture,
but that can be done from a reductionistic scientific perspective
or it can be done from a full-on God encounter.
I mean, it's a benevolent mystery that seems to be at play here,
and that's my experience of this, is quite akin to what many people would call God.
I remember very, very distinctly coming out of my first ever trip to Antarctica with a dear friend,
Matt Mullenweg, in fact, who you know as well, because he was one of the
co-funders of the Center at Hopkins, great human being. And I had just returned to land that was not ice.
In this case, it was in Chile.
And suddenly had cell reception, or at least Wi-Fi.
And I received your text.
And we had a conversation.
I reached out to you and we spoke about your diagnosis.
And we have a number of mutual friends,
close mutual friends.
And it's been remarkable to me in all of them how you have been able to thus far,
and I'm sure there's a lot behind the scenes,
of course, that we don't see, but navigate and integrate and view this experience from different perspectives.
And certainly not with rose-colored glasses.
I think that's what makes it so impressive to me and to other people.
You're looking at the diagnosis and possible trajectories
in a very sober way. But at the same time, like at the very beginning of this conversation,
you're laughing and we're talking here and I mean, you seem like good old Roland to me,
right? It doesn't seem like you have sort of psychologically succumbed in the way that I have seen with, sadly, other friends who
have had cancer diagnoses, many of which have recovered, but they've been flattened,
psychologically flattened. And I'd love for you to just speak to your experience and to the extent
that what I'm saying sounds accurate, what has enabled you to do that?
Well, let me start with the beginning of the diagnosis.
So this was a routine colonoscopy.
I viewed myself as incredibly healthy.
I exercised regularly.
I watched my diet.
You know, I pay attention to, you know, factors that support my well-being. I went in and remarkably came out
with this stage four colon cancer metastases to liver. And initially, I just was Marla, my now
wife, and I were just kind of thrown into a situation where this couldn't possibly be real.
This had to be some kind of dream. And so I think I spent a couple of days there not being able to
even process the reality of that. And then when subsequent tests came back confirming the highly suspected metastatic aspects of the disorder, then kind of
the full implications of that came upon me. And what I would say is initially, it was like shell
shock. There was just, okay, what do I do with this? And then in very short order, over a few days,
I started exploring all of the places where I could go psychologically with this diagnosis.
And one, of course, would be just sheer out fear or panic.
One would be depression.
And I woke up, you know, this is in that first few days,
at one point in the middle of the night, with this kind of deeply flattened affect,
and thinking, what is this? And I thought, well, if I went to describe this to someone,
they would surely say, oh, you're deeply depressed. And I thought, okay, yeah, I can see how that can happen.
And that's not a good place to go. And then there are other things you could choose to
be resentful. I could have chosen to be upset at my provider that had, in retrospect, a longer than
ideal callback time for the colonoscopies.
Mine was at five years, but I'd had polyps before.
And I think in retrospect, I wouldn't encourage anyone to follow that.
There's fighting it.
You know, I'm going to beat this sea, you know, go into war with your body over it.
I'm going to kick all the cancer centers out, as one of my
daughters said to me on one of my first days of treatment. She said, Dad, kick cancer's ass.
And I appreciated that thought, I mean, because positive thinking is really good to health outcomes. But I didn't
want to go to war with anything. But, you know, I wasn't about to roll over and be dead. I mean,
then it really quickly came to me that the experience and the practice should be gratitude
for the preciousness of human life and everything that I have. And I think with that came almost this immediate awakening, this clarity,
you know, okay, I'm going to reset my life priorities now.
I mean, I looked at my to-do list and go, okay, maybe half of those things
are just not that important now that I have some kind of constraints on my life horizon.
So there was a level of clarity that came into focus.
And then I think I would have to credit my long-term meditation practice,
and there are other practices as well that I've done along the way that we could talk about at some other time.
But my long-term spiritual practices in combination with psychedelic experiences,
which also can be spiritual practices. But I think that enabled me in a way that I wouldn't
have predicted. And I'm kind of humbled that I've been able to achieve
the level of equipoise and well-being from this to date. But I don't know what the future holds
for me. So I'm kind of humble. I don't want to over-claim that I got this nailed. But at least initially, what came up is an intense practice of mindfulness
in which I could see these different psychological rabbit holes. If you went down them,
you're not going to be happy. And I was able to identify those as soon as they came into vision
and just choose, I'm not going there. That's self-defeating. And so I think it's that
that has sustained me. And people ask me, well, you know, I tell them I have this cancer diagnosis
now. And they say, oh, I'm so sorry. That must be so awful. And my response to date has been,
no, you're not understanding. This is something, I'm more alive, I'm more awake,
I have a much deeper sense of equanimity and joy than I think I ever have had in my life.
And I'm sharing this with my partner. And what a tragedy it would have been had i walked out of my house the morning of the
colonoscopy and gotten run over by a bus i mean you know that would have been a lost opportunity
to awaken to a degree that i previously considered myself to be a way, but this was order of magnitude different.
So I consider authentically the diagnosis to be a blessing.
It's an opportunity for practice, but when people ask me how I'm doing, I commonly say never better.
There have been serious weighing about whether or not I wanted to engage in treatment and what kind of treatment and at what cost to staying awake and being present and doing the things that
are still are most important for me to do. Does that answer the question, Tim?
It does answer the question. I'd like to add something to that from my recollection, which was that first conversation we had when I got back to South America and we were talking about it. And I might be getting the phrasing slightly off, but I recall you saying to me,
every day is Thanksgiving. Like every day I wake up is Thanksgiving. And that didn't seem
accidental, right? It seemed like a choice and maybe on top of that, a practice. Is there anything
you'd like to say about that? It stuck with me.
Yeah. The diagnosis was made late November, so Thanksgiving was in my mind. But that's actually the core of my practice. It's gratitude practice. And it's gratitude for the preciousness of this
experience that we're having right now, if we allow ourselves to get out
of our mind enough to have it. And that, of course, is the trick. We get encumbered by the narrative
structure of what we think is going on, and we get caught up in that. And then we lose
track of the magnificence of every single moment, if you just allow yourself to enjoy it,
appreciate it for everything that it offers. That's my go-to practice. I've been doing
gratitude meditations every morning since the diagnosis. And I think that's the core way of leaning into this.
I drop the phrase every day is Thanksgiving because it's so associated with turkey,
but it is about the preciousness of life. What does your gratitude meditation
look like? What constitutes your gratitude meditation?
It varies. I mean, the core of it is, yeah, I mean, the practice would be anywhere from
10 minutes to an hour or more. And during some periods of time of the initial diagnosis and some
of the procedures, when my sleep cycles were totally dysregulated.
I spent hours actually at night in gratitude meditation. But it's just leaning into the joy of
what this experience is. And in fact, it's kind of interesting, some of the most clear experiences of present moment
and joy have been at times where I've been undergoing surgical procedures, like
I already had two intravenous ports placed because one became infected.
You know, and so that's a surgical procedure.
They usually anesthetize people with fentanyl and with a benzodiazepine,
and then they use a local.
And I said, I don't want anything other than the local.
Let me stay awake for this.
And it was an incredibly joyful, interesting kind of experience to have.
What does the procedure look like, if I might ask,
since I don't know what it looks like?
Are you just looking down at your abdomen while they're up to their elbows?
No, I can't imagine that.
No, you're flat out.
You're in a surgical operating room.
You're laid flat on the bed.
They actually put some kind of hood over or some curtain between you and the
serial field. So you're not looking at anything but a curtain and then you're just laying there
for the procedure. It wasn't a big deal. I think that the anesthetics that they give are because people get so tense and anxious that they don't want to experience anything.
And you could feel them mucking around in my chest to run the catheter, but it wasn't a big deal.
And they gave me local anesthetics.
So it actually turned out to be fun.
I have enjoyed that. I've had also
some sustained MRI procedures that were similar. I actually reached amazing degree of pure awareness
practice during some PET scans. So I hate to say it. Yeah, I almost kind of look forward to some of these surgical
interventions. Now, recently, I just had a procedure, liver embolization, which is essentially
they go into the abdomen and inject some kind of glue into some of the venous structures of the
liver. And essentially, it just knocks that liver,
in this case, my right liver lobe out. And so I was talking to the surgeon and saying, look,
can I do this without anesthesia? And he convinced me that that was not the right idea
because there'd be real significant pain that they couldn't manage. But I tried. It's almost like
you lose this opportunity to be awake for something really interesting and important.
You know?
Yeah. What other practices, you mentioned other practices, aside from the meditation that you've described have been
helpful supportive in allowing you to face has two negative a connotation but to
now let's just navigate again navigate your experiences over the last say six months
what other practices have been helpful?
It could be other meditation practices.
Quick definition of terms.
You said pure awareness.
Is that something akin to open monitoring,
if that makes any sense?
When you said you achieved that during, say, the surgical procedures
where you didn't have general anesthetics.
You see, no, it's different than open monitoring.
So that's, open monitoring would be more like
a sense that you're watching your mind
and you're watching things arise in consciousness.
Like a Vipassana meditation.
Yeah, and then fall back.
Awareness of awareness practices are,
they're prioritized in some traditions as kind of being the ultimate. I certainly can't claim to have any kind of stability with respect to
pure awareness practices. But it comes to a point where you're in the field of awareness
and nothing is arising. There is nothing within that field of
awareness other than awareness itself. And so the body drops away, thoughts drop away,
and you're in a state of pure awareness. Sometimes those experiences are magnificent.
They can almost be described as sat-chitatchitananda. It's consciousness and bliss. And they're very interesting experiences. conditions comes closest of all the psychedelics to producing such experiences, although mileage
may vary. There can be a lot of variations in those kinds of experiences. I can say, I don't
think you and I have ever discussed this, but I have some experience with the 5-MeO DMT. I happen
to think it's a very big gun, so I have some very real concerns around its therapeutic use. As you know, it's only 15 to 20 minutes in Earth time is not always the best argument for using a specific compound. the right dosage, well, the right dosage at certain dosages in the right setting,
that is my experience that you effectively can have. Not always. You can have some very,
very horrifying experiences too. And I've seen some very experienced psychonauts, people who have used, say, ayahuasca dozens of times who have become quite destabilized after 5-methoxy DMT. But putting all that aside,
my personal experience, I have on multiple occasions experienced effectively a
void of content, just a completely disembodied field of consciousness that does not feel
localized, but you are nonetheless observing.
What was the term you used?
It captures it pretty well, the consciousness and bliss.
Oh, yes, satchitananda.
Yeah, I would say that encapsulates the experience.
And when people ask me, what did I take out of it?
I'm like, it was a beautiful experience, but I could not give you any new story, any rewriting, any narrative.
I can't give you even a droplet of that.
Yeah, but that speaks to its ineffability, right?
Yeah.
So let me ask a question that I would never ask you on stage, but since we're just jamming
here, another experience I don't think I ever described to you that I'd love to get
your take on, and it could just be straight placebo effect, of course.
Although I feel like when people say, and even in this case, ah, it's placebo effect,
that that sometimes throws out the baby with the bathwater in the sense that even if it
is placebo effect, labeling it such doesn't really explain anything in terms of how the
hell it happens.
But let me
tell you what happens. So I have two experiences now, only two that come to mind, where I've
effectively had what I would describe now that we have the common vocabulary. I can't say the
Sanskrit, so I'll just say the 5-MeO experience as we've described it without any pharmacological intervention
whatsoever. The first was meditating and having a guru in this case, put his hands on my head and
I had no expectation of what would happen. So I wasn't coming in preloaded with confirmation bias,
and I had absolutely what I would describe as a 5MEO experience. And talking to,
I hate using this word guru. In Indonesian, at least, it just means teacher. But let's use it
in the more Indian sense, or at least the Western use in the Indian context of the term guru, right?
Like this master met with an Indian master maybe two years later, and he said, oh yeah.
In his pretty basic English, he said, oh, it's just pranic shock. It's a trick. It's a cheap trick.
Basically, he's like, yeah, yeah, that happens. That's pranic shock. That guy doesn't know what
he's doing. That's a cheap parlor trick. So that's number one. And then the second one was being in a very deep massage state. And the
massage therapist, this was in Montreal, asked if she could use tuning forks with me. And I've never
had anyone before or since in a massage therapy session ask this, but she did. And she took two different tuned forks and
put them on opposite sides of my head. And again, basically instantaneously had this spontaneous
5-MeO experience. And I've been trying to track her down since I have not been able to find the
contact information. What would you make of either of those? And maybe the answer is there's nothing
to be made of it.
But just, again, since I'm pushing a little bit, what comes to mind as I describe these two things?
I'm not at all surprised. You know, these altered states of consciousness, some of which we've come to know through psychedelics, you know, can also be elicited under any number of other conditions.
And presumably prior to psychedelics, that's exactly what happened.
I mean, so if you look into mystical traditions and meditation traditions,
yeah, these things can happen.
So we're biologically wired to have these experiences,
and we just don't understand the optimal conditions under which
they occur. So, you know, the guru experience is interesting. In the Siddha yoga tradition,
you know, there are all kinds of stories that really don't seem to make much sense unless you actually believe that the guru, you know,
has these remarkable powers of transmitting something and how that's transmitted, you know,
and how much of it is, you know, expectancy effects versus not, but there are hundreds of accounts of some of these most outstanding or notable
gurus in which people without any expectation come to awaken or have profound experiences
in their presence.
So I don't know what, I mean, that's one of those things that makes me kind of deeply curious. But so far, we don't have anything that approaches scientific proof that that occurs or can even occur reliably.
So it's part of what needs to be investigated.
And that would get to kind of the longer-term project of the endowment on spirituality, secular
spirituality and well-being.
I want to talk about that.
I want to, if you don't mind, just pause for a second to ask you a question about the two
cases I described.
So in, let's just say, with respect to investigating, and I'm probably going to script the vocabulary, so
please feel free to correct me. I should have said expectancy effect, not confirmation bias
as an example. I'm just dangerous enough to be wielding these labels without really understanding
what the hell I'm talking about, but I'll make an attempt. So if we look at, say, some of the
psychedelic research out there, and if we're looking at some of the, let's call
it classic psychedelics, and we can introduce the drug, and then maybe one model of explaining
the effects would be, we introduce this drug, it binds to any number of things, but very often to serotonin type 2a receptors,
and then that produces this effect. If you were to form a hypothesis around,
let's put the guru piece aside, the tuning forks, mechanistically, what could be happening
in a case like that, or in a case like meditation, for instance, because I've spoken with
some folks who take a counterpoint to meditators who would say psychedelics are cheating. They're
brute force. You're not really taking anything away. We meditators are doing it naturally,
therefore it has higher value. But the counterpoint would be you're doing the same
thing. Ultimately, if our experience is mediated by neurochemistry, you're just finding another way to somehow do something similar,
if that makes any sense. Basically, if we, within the lab, looking at, say, a serotonergic agonist,
we say, okay, this molecule binds to this, and the effects are as described sort of subjectively
by the patient and also as recorded in this fMRI machine. If it were, say, a tuning fork that
produced a similar experience to, say, 5-MeO-DMT, what are the mechanics by which it exerts that
similar effect? Because it's not a chemical that's
binding to anything, right? It's not an exogenous chemical.
Presumably, whatever these experiences that are occasioned with psychedelics are producing
interconnectivity and network changes within the brain, right? And that accounts for the experience. This is from the kind of the reductionistic neuroscience viewpoint. And so then the question is, well, yeah, what with tuning forks, you know, different frequencies going into different ears, I mean, that's a very unusual set of conditions.
You're totally relaxed.
You're totally comfortable otherwise.
And so it would be really interesting. And this is part of the comparative experimental work that needs to be done,
is once we have a good signal of what accounts for that pure awareness state under 5-MeO,
and if that can be replicated with tuning forks,
then you want to compare brain activities during that time.
And so in principle, there should be a way to, you know, examine those similarities and conclude, you know, what's operative under both conditions.
And the same would be true of meditation states. But our understanding of the nature of these experiences is so primitive
and our mechanisms for inquiring about brain structure, or not structure, network complexivity
are so crude at this point that I don't think science is up to the task to fully answer that.
But that is the project that is unfolding, and there are many laboratories that are interested
in just that. I'll have to make some phone calls to the director of the Tuning Fork
lobby to see if I can drum up some funding. That's another challenge, just getting funding for this stuff.
Yeah.
Well, you know, the same would be true of breathwork.
You know, under some conditions, particularly in some people,
breathwork can result in also similar kinds of changes.
It's just that there's so much variation, you know,
among meditators or
breathwork practices, and I'm guessing tuning fork massage therapists, that it's hard to mount
a prospective study because you'd have to identify conditions under which,
you know, those experiences can be elicited reliably. And so that is the power of psychedelic
drugs is that, you know, not in all people, but in most people, you can occasion a set of
phenomenological events that have definable phenomenology, definable experiential aspects. And so that leads us to be able to
study those effects prospectively with kind of the tools of empirical science. And that's made
much more difficult under conditions where you can't reliably occasion the experience.
After my initial engagement with Siddha Yoga, then I started
exploring other meditation traditions. I started, and I was drawn kind of most prominently to
Buddhist practices. So I worked some with Alan Wallace, who comes out of the Dalai Lama Tibetan school,
but probably just pragmatically ended up spending more time with Vipassana meditation
as taught by the Insight Meditation Center, and they have a retreat center in Barrie.
Why did you say pragmatically? Just because it was easily available?
Yeah, easily available? Easily available, yeah. And Tara Brock and Jonathan Faust are local to us and interested
in the work that we were doing. So my practice has turned more Buddhist. I like the insight
meditation practice because it strips away any theological or dogmatic practices.
It doesn't appeal to magic mechanisms or supernatural phenomena.
It's very worldly based, but yet it still has some of the flavor of the other kinds of traditions in terms of the enlivening quality of it.
And it's a much easier practice to understand and rationalize from a scientific worldview.
So I did that. And then I got involved with a local teacher who, you know, Jessica Dibb, who is, her central practice has been breath work,
and that is kind of this structured breathing practice that brings you into presence.
But she also teaches a series of courses, and what I would describe, I'm not sure how she would describe it, as embodied awakening. And so at the point that I encountered her, I had 15 years or more of sitting meditation practice. And so I had that kind of discipline down. But that's a very kind of narrow sense of practice, right? I mean, you're sitting on a cushion, meditating, and the objective is to
bring that into the world, you know, but how to do that is a little bit mysterious. Jessica,
as a teacher, had a whole host of practices that just brought those same sensibilities into moment-to-moment awareness.
And some of those were bodily practices.
Some of them were variations on meditative practices.
Bodily practices meaning movement?
Yeah, movement, yeah.
But all focused on staying awake to the present moment.
An example like yoga, you know, yoga could be that,
but very often it becomes a routine practice that is certainly about the body, but it's not about
that blending integration of moment-to-moment awake awareness with what you're doing. And that was a significant gift to my own practice,
because it got me out of an introvertive practice, and that is focused inwardly as meditation does,
to an extrovertive practice in which you're still holding that sense of aliveness and degree of awareness,
but it's also projected into the world or it's projected back from the world,
however one might experience that.
But it's really the enlivening of everything there is.
And those are very different but very similar.
And so in the literature on classic mystical experiences, there's a differentiation between introvertive experiences, that is internal experiences, versus extrovertive in which all things become alive and you're in the world.
I think it's important to recognize both are true and there's great value in both.
And of course, that leads us directly to some of the queries about psychedelic experiences.
So our laboratory has focused on research in which we've given a psychedelic, mostly psilocybin,
under conditions where people are asked to put eye shades on and listen to music
so it's a intentional and container to produce an introvertive kind of experience but you know
as you know there are people who are you know have profound and serious use of psychedelics
who think that that's just an abomination, that you need to take these
compounds out in nature or within community. And those are all legitimate set and setting
conditions. And my own thought would be that it's kind of the marriage of what you learn from each
of those kinds of experiences that helps you bring that into your moment-to-moment
and daily lived experience.
How do you relate to death?
I mean, people have a million different takes on it.
There are different ways that people maybe console themselves or provide an ideological theological safety net right in the in certain
belief systems then you have the sort of richard alpert ram das you know it's like taking off a
shoe that's a bit too tight to transition not asking for anything in particular other than just how you relate to death, how you think about it.
Yeah.
Well, it's an ongoing contemplation for me.
Brett is a reductionistic neuroscientist, but open to all possibilities.
And so one scenario is, yeah, nervous system goes down.
It's like unplugging the computer.
You know, that's the end of existence.
And then there are other scenarios that would have different accounts for survival of something,
consciousness or some type of awareness post-death. I guess what's clear is I cannot bring myself
to embrace the most fanciful thoughts about what death and dying are.
I'm going to go to heaven and sit on the right-hand side of Jesus
and be with all my loved ones,
or whatever story some people can embrace.
I have to think that if you actually believe that,
it could be joyful to die.
But that seems outlandishly improbable to me.
So I can dismiss those out of hand.
So then it's really kind of what the probability is that there's, you know,
something beyond death. You know, and I had these conversations with my cancer patients,
and this was, you know, we ran the cancer study that was published in 2016. And there's some irony, of course, in my now being one of those patients.
I would often ask, I always ask participants at the beginning of the study,
well, yeah, what do you think happens when we die?
And some would say, oh, yeah, I'm going to go on and meet my parents
and it'll be a joyful reunion.
And then others would say, well,
I don't believe anything. It's computer off, system down, nothing. And then what I would ask
is, what's the probability to think that's true? Are you absolutely certain about that or something?
And they'd say, oh, I believe that to be true. So 95%, they'd say. And I would think,
95%. So 5% likelihood that would be true. That would be, I mean, if you had lottery tickets
that were going to pay off at 5%, you'd buy them immediately. I mean, it's like people investing lottery tickets at odds of, what, one in,
you know, a million or less. So, I thought, well, that's interesting. And I think all you need is
a fraction of a percent. It can be as tiny as you want, but if you haven't foreclosed on the possibility that something might occur that's
interesting at the time of death, then that, at least to me, psychologically changes the whole
game. So I'm strongly biased toward kind of a reductionistic, powers-off scenario, but I'm open to the possibility, although the probability I put on
that changes from time to time, but it's really narrow in any case, but I'm open to the possibility
that something other might occur. And so that gives me this kind of deep curiosity about death. And I think that's, at least for me, that's all you need.
I mean, that's like, this story could be revealed.
I mean, you might pass through that gate and go, oh, this is what that was about.
You know, the curtain comes back and you see what's going on.
I mean, you know, but that's a fanciful idea in and of itself.
But yeah, I think I revel in the idea of curiosity at the time of death.
Now, whether that's going to change as I proceed through the medical course in my diagnosis, I don't know. And I don't know whether
I'm going to be able to maintain the degree of equipoise I currently have. And I don't know that
I'm not going to succumb to the rabbit holes. But I'd also say that I'm looking forward to the challenge. I mean, it's like everything that comes up that could be viewed as, oh, that's terrible. Oh, I'm so sad to hear an opportunity to explore what that is. And it's partly for me
just embracing reality as it unfolds in the course of this illness.
How can your friends be most supportive to what you just described? Because I imagine
many people, myself included, don't really know how to
address or not address or speak to these experiences you're having as they unfold.
So I'm sure I have said at some point, I'm so sorry to hear dot, dot, dot, because I just
don't have a better replacement. Do you have any suggestions for, if I texted you and I said, Roland, how are
you doing? And you replied with something that most people might respond to with, I'm so sorry
to hear that. Is there a alternative that you might suggest? And this is for you specifically,
not saying this is general advice, but how would you like me to be supportive? Yeah, thanks for asking. That's an
interesting question. People very often are calling and say, oh, I hope you're feeling better.
Well, that priest disposes that I was feeling bad at some point. And I'm not embracing that or endorsing that at all.
And so when people say, I'm so sorry,
my immediate reaction is there's nothing to be sorry about.
I consider this a blessing.
I've never been doing better in my life.
However, as I now am encountering more physical problems,
best I can tell, all secondary to the medical treatment,
which is a little exasperating,
but I think it was the best course of action.
Yeah, there'd be no question that it would be nicer
not to be encumbered by that.
So what would I want friends to say?
Well, where I see it right now,
I want them to join me in the celebration of what my experience is,
and that is this deep gratitude for the preciousness of life.
And that's what I'm trying to communicate to people.
Let's all wake up.
You know, you needn't have this stage four cancer diagnosis, but there's a degree of awakening that's obtainable.
And join me in this celebration. But now putting myself in my friend's shoes,
they may not know what my current state is. They don't know what my current state is.
And so it feels like that they should offer some kind of empathetic sympathy. So what do I
think about that? I think the question is, been thinking of you,
how are you doing? Rather than, I hope you're feeling better, or I'm so sorry. And those are
ones that, you know, we've been talking about identifying kind of the rabbit holes that you
don't want to go into. I mean, I almost have this kind of visceral response to
people saying, oh, I'm so sorry, or I hope you're feeling better. And there's some people,
every time I communicate with them, I have to make that correction. That's not my experience
and not the way I want to hold myself in this adventure that I'm undergoing.
You mentioned that in the cancer study with patients prior to,
and I'm emphasizing prior to, that's at least what I heard,
the psilocybin sessions, you asked them what they thought happened when they died. So 95% confident,
pearly gates, meet all my relatives, happy reunion. 95% confident, lights out,
robot unplugged, and so on. Did you observe any patterns of change after the session?
I don't know if you revisited that question.
Maybe you were able to infer from the reports,
which I know you have people both verbally recount and also in some cases type out or write out.
Did you observe any changes there?
Yes, there are changes,
and it's in the direction that you might anticipate.
People are more open to the possibility of something occurring after death.
And we've seen that repeatedly.
We've seen that in our cancer patients, and we've given a number of surveys of belief
changes that occur before and after psychedelic experiences,
and we've also looked at belief changes that occur before and after near-death experiences
and psychedelic experiences. And under all those cases, people are more likely to endorse
something that continues after death.
So I think that's actually a very common feature of psychedelic experiences
more broadly in a study that we've just submitted to publication
about belief changes.
There's a shift toward more dualistic thinking,
that mind is somehow different than body.
So that would be different than a
purely reductionistic worldview that would say that your mind is nothing other than
neural functioning. But there's a shift toward dualistic thinking, and then there are a number
of other kinds of changes that occur. I like to pretend like I'm some kind of amateur scientist, but really,
you're the scientist, and I'm just this sort of plotting interloper who happens to be a big fan
of scientists and science and the scientific method. But I want to ask you, and this is
not to infer any belief, certainly on my side, I can't explain this in any way, but have you taken a look at or come across at any point? Let me back up. There are all sorts of stories, to use one of your words, fanciful stories of life after death, lots of bestsellers written with these either subtle or very direct kind of theological undertones. And you just can't know. Just like you can know that
you are aware of being aware, but I may just be some robot that's passing the Turing test,
some deepfake AI that happens to be on video here. Who knows, right?
So similarly, you can't verify these experiences that people are reporting from near-death
experiences necessarily. Maybe there are commonalities, and that's interesting at some
level. But I remember reading a book, and there are some chapters in this book. It's more of an
anthology put together by David. It was edited by David Presti, who's at UC Berkeley. I believe the
title is called Mind Beyond Brain. I'd's, I'd say 20% of it,
I wish they had left out because it is,
from my perspective,
doesn't really further the conversation.
It just muddies the water.
However, there's one section
and this has also been,
I believe, looked at quite closely
by an author and a journalist who's written for the New York Times named Lisa Keen, who has also looked at case studies gathered by researchers at, I believe, University of Virginia. Stories relate to very young children, in many cases two or three years of age,
recounting with sufficient detail a prior life that it could be confirmed and identified.
And this is interesting.
Again, no explanation, but in India, this seems to be particularly common,
where it's like, you know, 20 clicks from here, I am so-and-so who grew up in this village, and my brother's name is such-and-such, and I died in this way, and I used to do this.
And this is a two- or three-year-old, and lo and behold, they go, and they're able to confirm this person actually existed.
Not asking you for commentary, necessarily, but have you come across any of this?
Have you read any of these accounts?
Yeah, I've read those accounts. I've read some of the literature on paranormal phenomena more
generally. In neither case have I gone deeply enough into it to overcome my potential skepticism that there could be biases in the data as collected.
I mean, look, we have almost half of our nation believing the election was totally fraudulent.
So the ability of cultures to birth stories that are consistent with whatever worldview they want. So you'd have to look really
closely into who said what to whom and what kind of information would have been otherwise
transmitted or distorted. And for sure, I just don't know. I mean, I do know there are
people who have been involved with paranormal research like Presti at UC Berkeley,
who believe that there are, you know, real, fundamental, interesting things going on there.
I just haven't pursued those areas enough to kind of quell my skepticism. Of course, some of those, if you believe those accounts,
then it breaks down our whole paradigm for understanding reality, at least to date.
And so that makes it discomforting to scientists and reductionistic scientists altogether. But frankly, that's also
one of the great benefits in having psychedelics to study, because one of the phenomena that,
one of the belief sets of belief changes that occur after psychedelic experiences
of the type I was describing,
people are more inclined toward dualistic thinking.
They're also more inclined toward endorsing paranormal beliefs.
And so why would that be and what's going on there?
I don't know, but these are questions that should be studied.
But, you know, very early on, we were interested in merging the work on paranormal phenomena with psychedelics because of those associations. And we
ultimately concluded that we had our hands full in terms of conducting our psychedelic research, which has changed markedly since 2000.
But when we first got involved here,
it was a very iffy business,
and we felt like we could be shut down.
You didn't want to throw psychics and astrology in there
just to see if you could get that past the IRB?
Right, right.
Yeah.
So I guess the bottom line answer is, yeah, we've kind of avoided looking closely at that. And we have enough to do with what we have without getting involved. But it's certainly enticing. And anything that's paradigm shifting like that is hugely important i don't buy i mean a lot of what comes up in that
book i i raise an eyebrow uh with respect to and i you know that term paranormal is really
unfortunate it's just or i mean supernatural far worse of course just because i i feel like
and you and i have have chatted a bit about articles
written by physicists where there is, on one hand, what you said, a lot of truth to if even one or
two of these edge cases, forget about the majority, let's just say one or two of these cases happen to
be verifiable, it upends to what we take to be true from a paradigm level perspective.
Then on the other hand, you can say, well, if we start going big enough or small enough,
there isn't really a consensus on what the hell is going on to begin with,
if that makes any sense. And things get very bizarre and there's a lot of contentious debate and absolutely no consensus
when it comes to quantum level physics and so i do think there's a lot to to be explored and i have
to assume i mean it seems like this has always been the case that we have meant many paradigms
and it just seems inconceivable out what do you say, outlandishly improbable that
all of them are correct. I mean, there must be. There have to be flaws. I mean, we've always
thought that we have it mostly figured out, and we've never been correct to date. So I have to
assume there are some things that are missing. That's what science has to offer. I mean, we do
have this methodology, you know, for discovering replicable relationships. And science has been a
huge blessing to human culture. And so that's where I'm kind of strongly inclined to say that the wheels of science grind and begin to answer some of these questions.
Ultimately, they're going to be answerable, I think, other than the ultimate question.
And that's what the hell's going on here. You know, the more mundane questions about whether there's remote reading, ultimately
is there's going to be proof of that or not proof of that.
But so far, well, I won't go into that because I don't know the data well enough.
I agree with you.
Which is partially why, I mean, people are like, oh, do you want to prove that X, Y,
and Z exists?
I'm like, no, actually, I don't. And that wouldn't be, again, I'm not a scientist, but that wouldn't
be a very scientific way of going about it either. I mean, you can have a hypothesis, but
I do think a lot of these things that appear to be fictionalized accounts of anomalies will be
explainable at some point. It might be quite a distance into the future,
but I'm optimistic actually with harnessing a lot of these technologies that, I mean,
it is pretty wild that we can use quantum computing while still at some of the most
basic levels. We do not understand what's going on, but we can still harness the technology.
It is very interesting. I think our explanatory power will improve a lot
over the next five to 10 years by harnessing AI and other things. So I'm actually optimistic that
a lot of these things that look like sort of improbable anomalies, maybe they are improbable
anomalies, will nonetheless be explainable and therefore cease to be thrown into this bucket of say paranormal
which is just like oh it's such a negative connotation i will say though just uh
getting a little off track that when it comes to any mention of some of these things posed as
questions right that there is a lot of sort of calcified,
let me put it in a different way,
reactionary unscientific response
from people who are practicing scientists, right?
They say, well, that can't be possibly true.
And I'm like, well, that's not a very scientific response.
I mean, if you say the data don't support that conclusion
as of now, that's a fair response. But if that's bullshit, that can't possibly exist, that's also not a terribly
thoughtful response to things. But like you said, let the wheels of science grind. And I will
just say that for me too, looking at the scientific method, looking at Western science
and medicine, I mean, these are, in the last case, I mean, the most successful healing system ever devised by
humankind, right? So I lean heavily in your direction as well with respect to all those things.
In some respects, science can become a religion in and of itself, and that's what you're talking
about, is people who, you know, have totally bought into a reductionistic worldview. That's the only way to look at it.
End of story. And they're just as close-minded as, you know, QAnon supporters, as far as I'm
concerned. Yeah, so science itself is entirely open-ended and agnostic. All it's trying to do is find out what's true.
And there are things that have come to be proven sufficiently well that we believe them
to be true. And then there are things that haven't reached that threshold yet.
But we have a methodology that can answer these kinds of questions.
Would you like to speak to the NDAAD professorship, just to introduce that? I mean,
I'd like to know why is it important, and what type of research do you hope to be conducted? What types of things do you, in your sort of dream of dreams, what kind of stuff would we be
investigating?
With the diagnosis, you know, I ended up starting to reprioritize a whole bunch of things in my
life. You know, some became more important, some became less important. It was very clarifying.
It's interesting because Marla, my wife, and I have done on several occasions the exercise of,
oh, so what would you do differently if you knew that you only had a year to live, a month to live, or a week to live, or a day to live?
And so we had been through that, but this brought that exercise into kind of crystal clarity for me in a way that I hadn't previously experienced it.
So among the things that came up, of course, was my will and, you know, what does that look like?
And so I started reworking my will.
And I got to the point of charitable contributions.
And my first response was, oh, that's simple. I'm going to give to, you know, the effective
charities movement, like Giving Well, which is this kind of leveraged group that really studies
different charitable causes and makes decisions and
prioritizes those that are most effective. Yeah, givewell.org.
Yeah, yeah. Terrific. And so that was my initial response. And then I woke the next day to the
thought, and I may get a little emotional about this, what would I really want to give? What
could I give that would be of most value and of most meaning? And what came up for me is
precisely the path that I'm on. What we want, those of us who have done spiritual practices and have experience with psychedelics,
is we want the world, humankind, to awaken to what this marvelous experience is and appreciate it.
And with that kind of awakening comes this, you know, sense of wanting to take care of one another,
to take care of the environment,
to make a difference at the most fundamental level.
There are aspects of moral thinking,
doing unto others as you would have them do unto you,
and pro-social behaviors and attitudes
that emerge from these kinds of transcendent experiences,
whether they're psychedelic or not.
But psychedelics seem to be a very important scientific tool.
So then the contemplation is, yeah, that's what I want.
What I want for humankind is for them to awaken.
Can I contribute in any way?
Because I think that some of the research we're doing is directly germane to awaken. Can I contribute in any way? Because I think that some of the research
we're doing is directly germane to that. And I thought, oh, you know, I could leave a bequest
in my will, and I don't have a big estate, but I could maybe sponsor an enduring endowed lectureship,
you know, where someone would come to lecture on this. And so that felt right. And then I thought, you know, I probably have, you know, there's some
goodwill that I've accumulated with respect to the work that I've done with psychedelics. So
maybe I should reach beyond that and create a professorship, a position that's dedicated to studying these very things.
And ideally, a research fund that would allow continued research into something that I call secular spirituality and all I'm meaning is an empirical scientific approach to studying
the effects of psychedelic compounds or interventions that produce psychedelic-like
effects to the empirical study of those aimed at healthy volunteers with the aspirational idea that that's going to feed into a deeper
understanding of the mystery in which we live. And if that can alter culture, that's fundamentally important. And my thought actually is that it's one of the most powerful ways that we could potentially alter culture.
And I don't mean by that to suggest that everyone should go out and take psychedelics.
I think they're much too powerful a tool for that, and they're potentially culturally disruptive. But to let the wheels of science
grind on those questions, I think, seems to me to be critically important to kind of solving
the problem of what these transformative experiences are, and then how they can benefit humankind and human flourishing. And in some sense,
I feel like we're in an existential race against the development of technologies that could end
this whole experiment. I mean, they're extinction-producing events like bioweaponry or nuclear war or climate change or AI, to name a few.
And so our technology is advancing at a rate much more rapidly than kind of these evolved
sense of moral ethical standards. And, there's every reason to give this area of research a high
priority. Ironically enough, that we got deeply involved in this research and sometimes credited
with setting off the Renaissance, psychedelic Renaissance. But ironically enough now, funds are flowing into the area of psychedelic research.
But they're doing so solely in support of therapeutic ends.
And don't get me wrong, a major focus of our research has been on therapeutic populations
like depressed patients,
anorexic patients, end-of-life cancer patients. That's really an important target, and it's an
understandable cultural target that it should be prioritized. However, those funds are coming in
from private capital to gain economic leverage, patent opportunities
that are going to be used for therapeutic indications.
I'm also optimistic that NIH is increasingly coming online, and we'll see money flowing
into the psychedelic area through the federal governments. But what's marooned in that process is this whole aspect
of the well-being of the populations that aren't otherwise identified as patients,
and the ethical and moral implications of those investigations. And so I think I've sometimes said it, and I think some people take
it as hyperbole, but in fact, I mean it. This area of research, you know, toward understanding
these benevolent, magnificent qualities or sensibilities that arise from these experiences and their attendant changes in pro-social behavior
are very likely to be critical to the survival of our species. It sounds like overreach, and
I don't believe it to be. So in kind of coming to that, that maybe I could play some role
in establishing a fund that would do that in perpetuity.
I mean, this is an endowment.
So what that means is it continues enduringly over time as long as Johns Hopkins as an institution continues to exist. And in terms of stable structures that we can expect to last for generations, I think
major academic centers are among those that would be the most trustworthy in that regard.
I see the question being addressed here, this idea of unpacking the mystery of what this
is all about, in a longer time frame.
And that may be a gift of the diagnosis.
I'm not, it's not, can we achieve this in five years?
And ultimately, the ultimate answer to what are we doing here
may never be known, but striving toward that is critical.
And this endowment will last in perpetuity and will grow in perpetuity.
It's managed by Hopkins in such a way that endowments grow over time. So I'm hugely
excited about the prospect of setting this in motion. What type of research could you foresee? Who's planned to head this up?
What might studies look like? And this might be a good place to bring in the religious leaders
study and maybe describe that if it seems like an opportune place. I'm interested in it. Certainly,
I think maybe at some point others would be as well. But would you like to address any of that,
the types of studies slash research that might be conducted, who you foresee heading it up,
since it is a professorship, and then the religious leaders study.
Let's see, so what kind of research would be done?
Well, I see this as actually a through line of the research that initially got me involved in this,
and this was the inquiry, would psychedelics have anything to tell us about the mystery,
the benevolent mystery of what it is to exist?
And so, you know, that brought me into the field through meditation.
We've done a series of studies in healthy volunteers to show that these effects,
these kind of pro-social dispositional effects are reliable, they're dose-dependent,
and we can show them across different populations.
We then did studies in beginning meditators and long-term meditators.
Most recently, we've done a study in religious professionals, that is, clergy.
In each case there, in beginning meditators and long-term meditators and religious clergy, we're looking at different
populations with different histories and different belief systems, if you will.
And what we've shown in each of those cases is that psilocybin is producing the same
kinds of effects.
Sometimes they're interpreted a little bit differently,
but they're these deeply moving experiences.
And as you move into long-term meditators and religious professionals,
these experiences are resonating with some of the very things
that brought them into that area of interest.
So where could this research go in the future?
And so one very important question is,
to what extent are these experiences with psychedelics universal experiences?
I mean, we still have to parse apart, you know apart culture, set, and setting. We've been doing this in
different populations. An obvious additional population would be to study people who are
holding atheistic worldviews, hard atheist worldviews, and see how they interpret these experiences in light of that.
And if I were to guess, I would guess that the benevolent pro-social attitudes are going to
shine through whatever they claim their belief system to be. They won't use the God language to describe it, or they won't use spiritual to
even describe it, but I'm guessing they would fall back on the magnificence of what it is to be
human. You know, there are other groups that could be studied, you know, including philosophers,
different non-Western cultures should be studied. A very interesting
group to be studied would be monastics, deep, deep monastics, like from the Dalai Lama's
tradition. We studied long-term meditators, but those were generally U.S. citizens. But if we
could study monastics out of, you know, who have been studying,
who have been practicing decades in isolation, you know, that would be really interesting.
You know, we need to understand to what extent expectancies play a role in these effects,
and can we prime these different kinds of effects with different
construction.
I mean, I think I could go on and on with the kinds of studies that could be done and
there's no single study that's going to answer it.
One question is kind of a total concept intervention. What if you
really throw the kitchen sink at the possibility for these kinds of changes, giving well-curated
psychedelic experiences in supportive conditions that allow for maximizing the potential of these experiences to alter worldview in this kind of
fundamental way. Related to that are a really interesting possibility is to look at psychedelic
effects as rites of passage. So there are inflection points within lives, like the transition into adulthood,
thinking immediately post-college before someone has undertaken a career. That's an inflection
point in one's life. Other inflection points could be at marriage or the birth of the first child or retirement from vocation and, of course, death. Those are each
potential inflection points that would be really interesting to investigate with respect to how
psychedelic experiences could alter those. So there are many, many other kinds of studies. What I hesitate to do is outline a
single study because that's all it's going to be is a single study. And what I'm seeing this as a
multi-generational process. I mean, like I said, it goes on enduringly to investigate the very nature of this sense of wonder and pro-social attitudes that evolve out of those kinds of experiences.
So who's the first lucky recipient, so to speak?
First appointee, first quarterback.
Not sure how to best describe it.
Professor, obviously.
So I was delighted when I kind of thought of this idea and endowed professorship that I had
recruited into our unit. David Yadin comes out of Pennsylvania, has devoted his career to date to the investigation of transformative experiences,
but without psychedelics. So he worked very closely with Marty Seligman.
Oh, Seligman. Yeah, Marty Seligman of positive psychology.
David has been very interested in transformative experiences. And he certainly recognized when he
was doing this stuff, that there was something super interesting about psychedelics. And he certainly recognized when he was doing this stuff that there was something
super interesting about psychedelics. And so, we had recruited him in several years ago,
and my appreciation for what he has to contribute has done nothing but grow enormously. He's a rigorous, empirical scientist. His own personal story is one in
which he's had transformative experiences that got him enthralled with answering these
kinds of questions. He's an incredible collaborator. He collaborates kind of naturally
with people. He's very productive.
And so I can't think of a better person to initially take on the endowed fellowship.
I should say something just about what we're aspiring toward.
So in general, endowed professorships can be established at universities at rates of a couple of million dollars, two or three million dollars. But it's a little bit deceiving because recipients of those
professorships are receiving income from the endowment against their salary, but it only supports about a third at best of their salary.
So they're not free to study any given thing.
Yeah, they have to sing for their supper, right, and grants to supplement their income.
Yeah, absolutely. So in some ways, you know, those endowed professorships are illusory, at least within some academic centers,
including my own.
The first goal was to create an endowment that would cover someone's full salary so
they would not have to be concerned as long as they were productive.
They wouldn't have to be concerned about losing their job for lack
of funding. And then the next level was to create enough additional funding so that they would have
income for a research program. And, you know, the kinds of studies that I've already outlined are
expensive. And I think the initial goal of the endowment to create the professorship
was at a $10 million mark, which appears that we have reached. And I want to just express my
gratitude to you, Tim, for your oversized role in making that happen. We still have to go through signing agreements and
stuff like that. So we're still short in that respect. But ultimately, my audacious dream,
as I keep calling this, because it seems so improbable from the outside, from the onset, that it could even be established.
My ultimate dream would be an endowment of $20 million that would really provide significant research funding
to continue this work in perpetuity.
How did you come across David? And I'll certainly have more questions, but I'm just wondering how the two of you first connected. because he immediately identified what we were doing as really interesting.
And I forget what question he asked me,
but the other day we were talking
and he actually pulled up the email
and he was asking something about transformative experiences.
I mean, he has a very interesting life story
in and of itself because he's had these opening experiences.
He was very interested
in initiative, initiatory experiences. And part of his thesis research was he did back-to-back
marine boot camp, and he was interested in that as an initiatory experience. But that's one hell of dedication to go through a boot camp, come out the other side, and take that as a learning option.
And then I think within weeks, he went off on a month-long meditation retreat. So I can't imagine two more different kind of initiatory experiences than
Marine Boot Camp. Sweet and sour chicken of initiatory compliments. Yeah. But yeah, it also
kind of shows that he has his own practices, and he's a regular meditator. And so he has a good sense of the
basic phenomenology of this and bringing that back with his kind of scientific expertise and
also his just very positive personality and ability to connect and collaborate with people
make him a really good choice.
So he already has good connections with Harvard Divinity Schools and international reputation
and collaborations with other centers doing psychedelic research.
So I think he's just uniquely well-placed to take on the professorship.
So one of the interesting contemplations we went through is,
well, yeah, how protected can we actually make this?
How do we know that somehow this dream that goes on in perpetuity
isn't diverted for some other reasons.
And it gets,
it gets the mission becomes distorted in a way that we didn't intend.
And so I had the great good fortune with working with remarkable lawyer who
did this on a pro bono basis,
but it really helped us work through the formal agreement
with Johns Hopkins that creates boundary conditions under which decisions about the
professorship need to be made. So we've written into know, very strong language about what the intent and purpose
of the professorship is. And then, in addition to that, within the agreement, we hold Johns Hopkins
accountable to evaluating the person with respect to the purpose and intent, and the point that they need to replace that person,
they have to replace it with deep consideration of the purpose and intent, so much so that,
although we can't and it wouldn't make any sense to try to take the final decision away from Hopkins, we require that they involve in that decision-making process
at least two other major institutions that have focuses germane to the purpose and intent.
And right now, we've chosen Harvard Divinity School. They have a deep interest in psychedelics and the USONA Institute out of
Madison, Wisconsin. So Hopkins has to confer with those two institutes and those two institutions,
and then as well as two or more professional researchers in the area that are doing research in alignment with the intent and purpose.
So what we're really doing is requiring a group of people to opine on decisions having to do
with whether this endowment is on track and whether the person appointed to the endowment is the right person.
So I feel very good about that in terms of kind of securing its future direction to be consistent with what we laid out as the purpose and intent of the endowment.
Very quick question, and this is going to be maybe a boring procedural question,
but Harvard Divinity School I don't think is going anywhere.
I expect that'll be around for a long time. USONA, less track record, not as I wouldn't
immediately have confidence that USONA will be around in 50 or 100 years. They may be,
and I have a great deal of respect for them, but is there a contingency for if USONA ceases to exist, a replacement, kind of plan B and C?
Yeah, absolutely.
Yeah.
So if those institutions are no longer doing research with respect to the purpose and intent of the endowment, then Hopkins has the right to choose another institution.
But yeah, those are the tricky kinds of decisions to be made.
Certainly Bill Linton from USONA is setting up USONA to survive in perpetuity,
but there are all kinds of unknowns that we can't account for.
But I think we have enough redundancy built in between the institutions and then the individuals that we have pretty good check on Johns Hopkins following what was intended. curiosity, but if you're open to telling me, what is the current prognosis? Where do things stand?
Where do you see things going with respect to your medical diagnosis?
Yeah, Tim, I'm totally open to talking about anything. One of the funny things that's
happened to, well, maybe it's not funny, but one of the things that's happened since the diagnosis is that I just feel this transparency
that there's no reason, but there's every reason not to be totally authentic and honest with myself
and with others.
So there's nothing you need fear to ask.
Let's see, so the prognosis.
So it's metastatic stage four, but there are variations.
There are metastatic stage four colon to liver cancer for which complete cures might be achievable.
This appears not to be one of those for several different reasons. There are actually some very good immunotherapies for
some forms of colon cancer, but the immune markers aren't favorable to that intervention.
And then it really depends on the extensiveness of the liver metastases. And unfortunately,
you know, I have metastases in multiple lobes of the liver.
And so when you ask the medical providers, it's very difficult to get them to give you kind of the raw straight answers of survival possibilities. I mean, but they're, you know, they're healthcare providers, and, you know,
and they're just not, they're not trained to do that, and they want to protect people from
unnecessary fear. None of them will say, oh, yeah, there's no chance that you're going to survive.
They all say, well, yeah, there's a possibility here. And I may have told you at one point, I asked one of the surgeons, I said, okay, well, so
given what you know about my cancer and, you know, and the risk factors and the distribution
of it, I said, how many patients have you have that are still around 10 or 15 years
later?
And he said, oh, well, that's just not a fair question to ask.
And so I kind of teased him about that subsequently.
But yeah, but clearly, had he had one case, he would have jumped on it.
So, well, yeah, just two months ago, I met with someone who...
But nonetheless, I guess the possibility of complete cure remains,
but my thought is that it's a theoretical possibility.
And I also, you know, it's interesting in terms of just how I'm dealing with it psychologically.
I've read some books on people going through terminal cancer.
And I think one of the toxic things that comes about is this grasping for the next therapy,
you know, that, oh, yeah, this is going to work and I'm going to be cured.
And I don't want to paint myself as hopeless, but that feels toxic to kind of grasp for
straws. Oh, yeah, all I have to do is get
through chemotherapy or there's a new experimental treatment. And, you know, and there's some people
who live out the course of their terminal diagnosis, chasing down the next possibility
to prolong life. But in so doing, they've given up the opportunity to participate
in life fully. And so that's a balancing act.
Roland, is there anything else that you would like to say as we're having this conversation
and recording? Could be to, just could be any closing comment, requests of people, could be any closing comment requests of people could be something you want to say to
your family or loved ones this is entirely up to you this is just whatever whatever feels right to
you which could also be nothing further to add the first thing i would say is just deep gratitude to
everyone who has helped support me and And then, you know, in terms
of what I'm going through personally, it's this celebration of the preciousness of human life,
of preciousness of awareness. And we're all in this together, you know, at the deepest level, people understand that. And so my invitation
to anyone who ends up hearing this in the future is to join me in that celebration,
even if I'm not around in bodily form. I mean, there's something so precious about that.
And then, of course, in line with what we've been talking about,
this endowment feels truly important to me.
It feels like it's a gift to humanity and what we all want
in terms of human flourishing for humankind
and for planet and for other sentient species.
And so whoever's moved to support that, that would be accepted with deep gratitude from me.
I guess the final comment would be to be continued because I don't know what lies ahead for me.
I don't know whether I can maintain the level of equipoise that I have.
I certainly hope to be able to do so,
but I'm taking it in real time as it comes up.
And so I don't want to give any kind of sense
that I've got this handled all the way to the end.
I'm looking forward to seeing how I encounter those potential challenges.
Thank you all so much for listening. To support Roland's very ambitious project,
and I do recommend that you consider supporting it. To establish a world-class
psychedelic research program in perpetuity to advance human flourishing and well-being,
please visit griffithsfund.org. That's G-R-I-F-F-I-T-H-S fund.org. Currently,
Roland has received pledges totaling around $14 million. That means that he is $6 million short
of the $20 million target sufficient to support the full research program.
To donate, please visit griffithsfund.org and click donate. For more information about
establishing a major gift, please contact Mike DeVito, that's D-E-V-I-T-O, the Senior
Associate Director of Development at mdevito1 at jhmi.edu or call him at 443-278-3174. Mike's name and email address and all the contact info will
also be added to the show notes for this episode at tim.blog.com. Donors who contribute $1,000 or
more and who do not choose to remain anonymous, so if you choose to be named,
you will be acknowledged on the website. Thanks so much, everybody.